Function	O
of	O
NF-kappa	B-DNA
B/Rel	I-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
major	B-DNA
histocompatibility	I-DNA
complex	I-DNA
class	I-DNA
II	I-DNA
invariant	I-DNA
chain	I-DNA
promoter	I-DNA
is	O
dependent	O
on	O
cell-specific	O
binding	O
of	O
different	O
NF-kappa	B-protein
B/Rel	I-protein
subunits	I-protein
.	O

The	O
promoter	B-DNA
of	O
the	O
human	O
major	O
histocompatibility	B-DNA
complex	I-DNA
class	I-DNA
II-associated	I-DNA
invariant-chain	I-DNA
gene	I-DNA
(	O
Ii	B-DNA
)	O
contains	O
two	O
NF-kappa	B-DNA
B/Rel	I-DNA
binding	I-DNA
sites	I-DNA
located	O
at	O
-109	B-DNA
to	I-DNA
-118	I-DNA
(	O
Ii	B-DNA
kappa	I-DNA
B-1	I-DNA
)	O
and	O
-163	B-DNA
to	I-DNA
-172	I-DNA
(	O
Ii	B-DNA
kappa	I-DNA
B-2	I-DNA
)	O
from	O
the	O
transcription	O
start	O
site	O
.	O

We	O
report	O
here	O
that	O
the	O
differential	O
function	O
of	O
each	O
of	O
these	O
NF-kappa	B-DNA
B/Rel	I-DNA
sites	I-DNA
in	O
several	O
distinct	O
cell	O
types	O
depends	O
on	O
cell-specific	O
binding	O
of	O
NF-kappa	B-protein
B/Rel	I-protein
transcription	I-protein
factors	I-protein
.	O

Ii	B-DNA
kappa	I-DNA
B-1	I-DNA
is	O
a	O
positive	B-DNA
regulatory	I-DNA
element	I-DNA
in	O
B-cell	B-cell_line
lines	I-cell_line
and	O
in	O
the	O
Ii-expressing	B-cell_line
T-cell	I-cell_line
line	I-cell_line
,	O
H9	B-cell_line
,	O
but	O
acts	O
as	O
a	O
negative	B-DNA
regulatory	I-DNA
element	I-DNA
in	O
myelomonocytic	B-cell_line
and	I-cell_line
glia	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

In	O
vivo	O
protein-DNA	O
contacts	O
are	O
detectable	O
at	O
Ii	B-DNA
kappa	I-DNA
B-1	I-DNA
in	O
cell	B-cell_line
lines	I-cell_line
in	O
which	O
this	O
site	O
is	O
functional	O
as	O
either	O
a	O
positive	B-DNA
or	I-DNA
negative	I-DNA
regulator	I-DNA
.	O

Electrophoretic	O
mobility	O
supershift	O
assays	O
determine	O
that	O
members	O
of	O
the	O
NF-kappa	B-protein
B/Rel	I-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
can	O
bind	O
to	O
this	O
site	O
in	O
vitro	O
and	O
that	O
DNA-binding	B-protein
complexes	I-protein
that	O
contain	O
p50	B-protein
,	O
p52	B-protein
,	O
p65	B-protein
,	O
and	O
cRel	B-protein
correlate	O
with	O
positive	O
regulation	O
whereas	O
the	O
presence	O
of	O
p50	B-protein
correlates	O
with	O
negative	O
regulation	O
.	O

Ii	B-DNA
kappa	I-DNA
B-2	I-DNA
is	O
a	O
site	O
of	O
positive	O
regulation	O
in	O
B-cell	B-cell_line
lines	I-cell_line
and	O
a	O
site	O
of	O
negative	O
regulation	O
in	O
H9	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
myelomonocytic	B-cell_line
,	I-cell_line
and	I-cell_line
glial	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

In	O
vivo	O
occupancy	O
of	O
this	O
site	O
is	O
observed	O
only	O
in	O
the	O
H9	B-cell_line
T-cell	I-cell_line
line	I-cell_line
.	O

Again	O
,	O
in	O
vitro	O
supershift	O
studies	O
indicate	O
that	O
the	O
presence	O
of	O
p50	B-protein
,	O
p52	B-protein
,	O
p65	B-protein
,	O
and	O
cRel	B-protein
correlates	O
with	O
positive	O
function	O
whereas	O
the	O
presence	O
of	O
only	O
p50	B-protein
and	O
p52	B-protein
correlates	O
with	O
negative	O
function	O
.	O

This	O
differential	O
binding	O
of	O
specific	O
NF-kappa	B-protein
B/Rel	I-protein
subunits	I-protein
is	O
likely	O
to	O
mediate	O
the	O
disparate	O
functions	O
of	O
these	O
two	O
NF-kappa	B-DNA
B/Rel	I-DNA
binding	I-DNA
sites	I-DNA
.	O

MoLEcuLaR	NULL
anp	NULL
CELLULAR	NULL
BroLoGy	NULL
,	NULL
May	NULL
1994	NULL
,	NULL
p.	NULL
2926-2935	NULL
0270-7306/94/	NULL
$	NULL
04.00	NULL
+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Function	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
Binding	NULL
Sites	NULL
in	NULL
the	NULL
Major	NULL
Histocompatibility	NULL
Complex	NULL
Class	NULL
II	NULL
Invariant	NULL
Chain	NULL
Promoter	NULL
Is	NULL
Dependent	NULL
on	NULL
Cell-Specific	NULL
Binding	NULL
of	NULL
Different	NULL
NF-	NULL
<	NULL
B/Rel	NULL
Subunits	NULL
ADRIENNE	NULL
M.	NULL
BROWN	NULL
,	NULL
'*¢+	NULL
MICHAEL	NULL
W.	NULL
LINHOFF	NULL
,	NULL
``	NULL
BERND	NULL
STEIN	NULL
,	NULL
``	NULL
;	NULL
KENNETH	NULL
L.	NULL
WRIGHT	NULL
,	NULL
ALBERT	NULL
S.	NULL
BALDWIN	NULL
,	NULL
JR.	NULL
,	NULL
``	NULL
PATRICIA	NULL
V.	NULL
BASTA	NULL
,	NULL
*	NULL
anp	NULL
JENNY	NULL
P.-Y	NULL
.	NULL

TING'**	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
and	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
``	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
at	NULL
Chapel	NULL
Hill	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
North	NULL
Carolina	NULL
27599-7295	NULL
,	NULL
and	NULL
Research	NULL
Triangle	NULL
Institute	NULL
,	NULL
Research	NULL
Triangle	NULL
Park	NULL
,	NULL
North	NULL
Carolina	NULL
27709	NULL
Received	NULL
25	NULL
August	NULL
1993/Returned	NULL
for	NULL
modification	NULL
16	NULL
November	NULL
1993/Accepted	NULL
27	NULL
January	NULL
1994	NULL
The	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II-associated	NULL
invariant-chain	NULL
gene	NULL
(	NULL
Ii	NULL
)	NULL
contains	NULL
two	NULL
NF-B/Re	NULL
!	NULL

binding	NULL
sites	NULL
located	NULL
at	NULL
-109	NULL
to	NULL
-118	NULL
(	NULL
Ii	NULL
and	NULL
-163	NULL
to	NULL
-172	NULL
(	NULL
Ii	NULL
KB-2	NULL
)	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
differential	NULL
function	NULL
of	NULL
each	NULL
of	NULL
these	NULL
NF-B/Rel	NULL
sites	NULL
in	NULL
several	NULL
distinct	NULL
cell	NULL
types	NULL
depends	NULL
on	NULL
cell-specific	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Ii	NULL
«	NULL
B-1	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B-cell	NULL
lines	NULL
and	NULL
in	NULL
the	NULL
Ii-expressing	NULL
T-cell	NULL
line	NULL
,	NULL
H9	NULL
,	NULL
but	NULL
acts	NULL
as	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
myelomonocytic	NULL
and	NULL
glial	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
vivo	NULL
protein-DNA	NULL
contacts	NULL
are	NULL
detectable	NULL
at	NULL
Ii	NULL
«	NULL
B-1	NULL
in	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
this	NULL
site	NULL
is	NULL
functional	NULL
as	NULL
either	NULL
a	NULL
positive	NULL
or	NULL
negative	NULL
regulator	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
supershift	NULL
assays	NULL
determine	NULL
that	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
can	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
in	NULL
vitro	NULL
and	NULL
that	NULL
DNA-binding	NULL
complexes	NULL
that	NULL
contain	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
cRel	NULL
correlate	NULL
with	NULL
positive	NULL
regulation	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
correlates	NULL
with	NULL
negative	NULL
regulation	NULL
.	NULL

Ii	NULL
<	NULL
B-2	NULL
is	NULL
a	NULL
site	NULL
of	NULL
positive	NULL
regulation	NULL
in	NULL
B-cell	NULL
lines	NULL
and	NULL
a	NULL
site	NULL
of	NULL
negative	NULL
regulation	NULL
in	NULL
H9	NULL
T	NULL
cells	NULL
,	NULL
myelomonocytic	NULL
,	NULL
and	NULL
glial	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
vivo	NULL
occupancy	NULL
of	NULL
this	NULL
site	NULL
is	NULL
observed	NULL
only	NULL
in	NULL
the	NULL
H9	NULL
T-cell	NULL
line	NULL
.	NULL

Again	NULL
,	NULL
in	NULL
vitro	NULL
supershift	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
cRel	NULL
correlates	NULL
with	NULL
positive	NULL
function	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
p50	NULL
and	NULL
p52	NULL
correlates	NULL
with	NULL
negative	NULL
function	NULL
.	NULL

This	NULL
differential	NULL
binding	NULL
of	NULL
specific	NULL
NF-	NULL
«	NULL
B/Rel	NULL
subunits	NULL
is	NULL
likely	NULL
to	NULL
mediate	NULL
the	NULL
disparate	NULL
functions	NULL
of	NULL
these	NULL
two	NULL
NF-	NULL
«	NULL
B/Rel	NULL
binding	NULL
sites	NULL
.	NULL

Proper	NULL
functioning	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
antigens	NULL
is	NULL
critical	NULL
to	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
HM-associated	NULL
invariant	NULL
chain	NULL
(	NULL
Ii	NULL
)	NULL
is	NULL
required	NULL
for	NULL
the	NULL
proper	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

This	NULL
was	NULL
recently	NULL
illustrated	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
Ii-negative	NULL
mice	NULL
produced	NULL
by	NULL
gene	NULL
ablation	NULL
technology	NULL
.	NULL

These	NULL
mice	NULL
were	NULL
deficient	NULL
in	NULL
class	NULL
II	NULL
function	NULL
,	NULL
had	NULL
altered	NULL
class	NULL
II	NULL
structure	NULL
,	NULL
and	NULL
were	NULL
deficient	NULL
in	NULL
T-cell	NULL
development	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
Ii	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
binding	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
heterodimers	NULL
in	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

This	NULL
blocks	NULL
peptide	NULL
binding	NULL
to	NULL
class	NULL
II	NULL
during	NULL
transport	NULL
until	NULL
the	NULL
complexes	NULL
reach	NULL
endosomes	NULL
,	NULL
where	NULL
Ii	NULL
dissociates	NULL
,	NULL
thereby	NULL
releasing	NULL
the	NULL
heterodimers	NULL
in	NULL
the	NULL
mature	NULL
and	NULL
correct	NULL
conformation	NULL
for	NULL
binding	NULL
antigenic	NULL
peptides	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
MHC	NULL
class	NULL
complex	NULL
can	NULL
then	NULL
be	NULL
recognized	NULL
by	NULL
T-cell	NULL
receptors	NULL
which	NULL
initiate	NULL
specific	NULL
helper	NULL
T-cell	NULL
functions	NULL
and	NULL
cytokine	NULL
produc-tion	NULL
.	NULL

Although	NULL
the	NULL
Ii	NULL
gene	NULL
and	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
encoded	NULL
on	NULL
separate	NULL
chromosomes	NULL
and	NULL
their	NULL
structures	NULL
are	NULL
unrelated	NULL
,	NULL
these	NULL
genes	NULL
are	NULL
to	NULL
a	NULL
large	NULL
extent	NULL
coordinately	NULL
regulated	NULL
.	NULL

They	NULL
are	NULL
expressed	NULL
on	NULL
the	NULL
same	NULL
cell	NULL
types	NULL
,	NULL
generally	NULL
B	NULL
lymphocytes	NULL
and	NULL
antigen-presenting	NULL
cells	NULL
,	NULL
and	NULL
they	NULL
are	NULL
coordinately	NULL
in	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
CB	NULL
7295	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
at	NULL
Chapel	NULL
Hill	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599-7295	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
919	NULL
)	NULL
966-5538	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
919	NULL
)	NULL
966-3015	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Molecular	NULL
Neurobiology	NULL
Laboratory	NULL
,	NULL
The	NULL
Salk	NULL
Institute	NULL
for	NULL
Biological	NULL
Sciences	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92186	NULL
.	NULL
}	NULL

Present	NULL
address	NULL
:	NULL
Signal	NULL
Pharmaceuticals	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92121	NULL
.	NULL

2926	NULL
duced	NULL
by	NULL
cytokines	NULL
.	NULL

Coregulation	NULL
is	NULL
accomplished	NULL
through	NULL
common	NULL
cis-acting	NULL
DNA	NULL
sequences	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
11	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
class	NULL
II	NULL
promoters	NULL
and	NULL
Ii	NULL
share	NULL
three	NULL
regulatory	NULL
elements	NULL
:	NULL
S	NULL
(	NULL
also	NULL
termed	NULL
H	NULL
,	NULL
W	NULL
,	NULL
or	NULL
Z	NULL
)	NULL
,	NULL
X	NULL
,	NULL
and	NULL
Y	NULL
,	NULL
which	NULL
mediate	NULL
high	NULL
constitutive	NULL
expression	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
-inducible	NULL
expression	NULL
(	NULL
8	NULL
,	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
several	NULL
situations	NULL
the	NULL
Ii	NULL
and	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
also	NULL
differentially	NULL
regulated	NULL
(	NULL
29	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

A	NULL
notable	NULL
instance	NULL
is	NULL
that	NULL
the	NULL
lymphocytes	NULL
of	NULL
patients	NULL
with	NULL
a	NULL
severe	NULL
immune	NULL
deficiency	NULL
,	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
,	NULL
lack	NULL
all	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
but	NULL
do	NULL
express	NULL
Ii	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
Ii	NULL
gene	NULL
contains	NULL
within	NULL
its	NULL
5	NULL
'	NULL
regulatory	NULL
region	NULL
DNA	NULL
motifs	NULL
that	NULL
may	NULL
regulate	NULL
Ii	NULL
expression	NULL
distinct	NULL
from	NULL
the	NULL
other	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
murine	NULL
Ii	NULL
gene	NULL
contains	NULL
an	NULL
SP-1-binding	NULL
site	NULL
and	NULL
an	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

site	NULL
(	NULL
52	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

element	NULL
in	NULL
the	NULL
murine	NULL
Ii	NULL
promoter	NULL
mediates	NULL
constitutive	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
52	NULL
)	NULL
and	NULL
mediates	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
response	NULL
in	NULL
fibroblasts	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
the	NULL
human	NULL
Ii	NULL
gene	NULL
,	NULL
two	NULL
NF-	NULL
«	NULL
B/Rel	NULL
binding	NULL
sites	NULL
at	NULL
positions	NULL
-	NULL
109	NULL
to	NULL
-118	NULL
(	NULL
Ii	NULL
kB-1	NULL
)	NULL
and	NULL
=-172	NULL
to	NULL
-163	NULL
(	NULL
Ii	NULL
«	NULL
B-2	NULL
)	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
have	NULL
been	NULL
noted	NULL
,	NULL
but	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
these	NULL
sites	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL
)	NULL

'	NULL
I	NULL
(	NULL
‘	NULL
he	NULL
)	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
of	NULL
transcription	NULL
factors	NULL
controls	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
through	NULL
NF-	NULL
«	NULL
B/Rel	NULL
DNA-binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
this	NULL
family	NULL
that	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
their	NULL
genes	NULL
cloned	NULL
include	NULL
the	NULL
p50	NULL
(	NULL
NFKB1	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
NFKB2	NULL
,	NULL
p49	NULL
,	NULL
or	NULL
Lyt10	NULL
)	NULL
,	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
subunits	NULL
of	NULL
NF-kB	NULL
,	NULL
the	NULL
proto-onco-gene	NULL
product	NULL
c-Rel	NULL
(	NULL
HIVEN86A	NULL
)	NULL
,	NULL
the	NULL
avian	NULL
oncogene	NULL
product	NULL
v-Rel	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
morphogen	NULL
Dorsal	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
NF-kB/Re	NULL
!	NULL

family	NULL
members	NULL
share	NULL
a	NULL
300-amino-acid	NULL
sequence	NULL
homology	NULL
,	NULL
termed	NULL
the	NULL
Rel	NULL
domain	NULL
,	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
proteins	NULL
.	NULL

The	NULL
Rel	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
dimerization	NULL
,	NULL
binding	NULL
to	NULL
cognate	NULL
DNA	NULL
motifs	NULL
,	NULL
nuclear	NULL
localization	NULL
,	NULL
and	NULL
interaction	NULL
with	NULL
IxB	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
exists	NULL
in	NULL
two	NULL
forms	NULL
,	NULL
either	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
as	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
or	NULL
alternatively	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
association	NULL
with	NULL
an	NULL
IxB	NULL
protein	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
activation	NULL
by	NULL
a	NULL
number	NULL
of	NULL
inducing	NULL
agents	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
,	NULL
lipopoly-saccharides	NULL
,	NULL
interleukin-1	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
calcium	NULL
ionophores	NULL
,	NULL
lectin	NULL
,	NULL
antigen	NULL
,	NULL
and	NULL
DNA-damaging	NULL
agents	NULL
such	NULL
as	NULL
UV	NULL
light	NULL
(	NULL
1	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
regulated	NULL
by	NULL
IxB	NULL
,	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
including	NULL
IxBae	NULL
(	NULL
MAD-3	NULL
)	NULL
,	NULL
IxBB	NULL
,	NULL
IxBy	NULL
,	NULL
and	NULL
the	NULL
p105	NULL
and	NULL
p100	NULL
proteins	NULL
(	NULL
the	NULL
precursors	NULL
to	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
molecules	NULL
sequester	NULL
NF-kB	NULL
subunits	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
inhibit	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
to	NULL
their	NULL
cognate	NULL
DNA-binding	NULL
sites	NULL
(	NULL
9	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
is	NULL
quickly	NULL
responsive	NULL
to	NULL
external	NULL
signals	NULL
,	NULL
and	NULL
is	NULL
thus	NULL
ideal	NULL
for	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
inflammation	NULL
and	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

This	NULL
work	NULL
shows	NULL
in	NULL
vivo	NULL
genomic	NULL
footprints	NULL
of	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
binding	NULL
sites	NULL
in	NULL
constitutively	NULL
expressing	NULL
and	NULL
IFN-y-inducible	NULL
cell	NULL
lines	NULL
.	NULL

Functional	NULL
analyses	NULL
of	NULL
these	NULL
sites	NULL
revealed	NULL
that	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

sites	NULL
serve	NULL
multiple	NULL
purposes	NULL
dependent	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
.	NULL

Ii	NULL
«	NULL
<	NULL
B-1	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
and	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
and	NULL
brain	NULL
glial	NULL
cell	NULL
lines	NULL
.	NULL

Ii	NULL
«	NULL
kB-2	NULL
is	NULL
a	NULL
positive	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
the	NULL
Ii-expressing	NULL
T-cell	NULL
line	NULL
H9	NULL
and	NULL
brain	NULL
glial	NULL
and	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
types	NULL
formed	NULL
different	NULL
complexes	NULL
with	NULL
these	NULL
NF-xB/Re	NULL
!	NULL

sites	NULL
,	NULL
and	NULL
these	NULL
complexes	NULL
are	NULL
composed	NULL
of	NULL
different	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
Ii	NULL
kB-1	NULL
and	NULL
«	NULL
kB-2	NULL
complexes	NULL
may	NULL
explain	NULL
the	NULL
opposite	NULL
function	NULL
served	NULL
by	NULL
these	NULL
NF-kB/Rel	NULL
sites	NULL
in	NULL
vivo	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

The	NULL
Ii	NULL
promoter-CAT	NULL
plasmid	NULL
7901iCAT	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
,	NULL
it	NULL
contains	NULL
the	NULL
Ii	NULL
sequence	NULL
from	NULL
positions	NULL
-790	NULL
to	NULL
+1	NULL
cloned	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
.	NULL

Constructs	NULL
with	NULL
mutant	NULL
promoter	NULL
elements	NULL
were	NULL
obtained	NULL
by	NULL
oligonucleotide-directed	NULL
site-specific	NULL
mutagenesis	NULL
with	NULL
a	NULL
ura-cil-containing	NULL
template	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
plasmid	NULL
Mut	NULL
«	NULL
B-1	NULL
,	NULL
the	NULL
sequence	NULL
from	NULL
-109	NULL
to	NULL
-118	NULL
bp	NULL
of	NULL
the	NULL
Ii	NULL
gene	NULL
was	NULL
changed	NULL
from	NULL
5-GGGGTATITCC-3	NULL
'	NULL
to	NULL
5'-TTTITTCTAGAA-3	NULL
'	NULL
.	NULL

In	NULL
Mut	NULL
«	NULL
B-2	NULL
,	NULL
the	NULL
sequence	NULL
from	NULL
-172	NULL
to	NULL
-163	NULL
bp	NULL
was	NULL
changed	NULL
from	NULL
5-GGGGAGCCCC-3	NULL
'	NULL
to	NULL
5-CCATGGCCCC-3	NULL
'	NULL
.	NULL

The	NULL
plasmid	NULL
Ii	NULL
«	NULL
B-1m3	NULL
mutates	NULL
Ii	NULL
<	NULL
B-1	NULL
from	NULL
55GGGGTATT	NULL
TCC-3	NULL
'	NULL
to	NULL
5-GCACTATTTCC-3	NULL
'	NULL
.	NULL

The	NULL
plasmids	NULL
kB-1TKCAT	NULL
and	NULL
«	NULL
kB-2TKCAT	NULL
contain	NULL
Ii	NULL
kB-1	NULL
and	NULL
Ii	NULL
kB-2	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
sites	NULL
inserted	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
BamHI	NULL
restriction	NULL
enzyme	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
promoter	NULL
in	NULL
pBLCAT4	NULL
(	NULL
48	NULL
)	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Cell	NULL
cultures	NULL
.	NULL

Raji	NULL
is	NULL
an	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
.	NULL

H9	NULL
(	NULL
derived	NULL
from	NULL
HuT	NULL
78	NULL
)	NULL
is	NULL
an	NULL
Ii/MHC	NULL
class	NULL
II-positive	NULL
transformed	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
and	NULL
Jurkat	NULL
is	NULL
an	NULL
Ii/MHC	NULL
class	NULL
II-negative	NULL
human	NULL
T-cell	NULL
line	NULL
.	NULL

U937	NULL
is	NULL
an	NULL
Ii-positive	NULL
,	NULL
class	NULL
I-negative	NULL
immature	NULL
monocytic	NULL
cell	NULL
line	NULL
isolated	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
histiocytic	NULL
lymphoma	NULL
,	NULL
and	NULL
WEHI-3	NULL
is	NULL
a	NULL
murine	NULL
myelomonocytic	NULL
line	NULL
.	NULL

All	NULL
lymphoid	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

WEHI-3	NULL
was	NULL
additionally	NULL
supplemented	NULL
with	NULL
5	NULL
x	NULL
10~°	NULL
``	NULL
M	NULL
NF-	NULL
«	NULL
B/Rel	NULL
BINDING	NULL
SITES	NULL
IN	NULL
MHC	NULL
CLASS	NULL
II	NULL
Ii	NULL
PROMOTER	NULL
2927	NULL
B-mercaptoethanol	NULL
.	NULL

U-105	NULL
MG	NULL
,	NULL
previously	NULL
referred	NULL
to	NULL
as	NULL
U-373	NULL
MG	NULL
in	NULL
this	NULL
laboratory	NULL
,	NULL
is	NULL
a	NULL
human	NULL
glioblastoma	NULL
multi-forme	NULL
cell	NULL
line	NULL
and	NULL
was	NULL
maintained	NULL
in	NULL
McCoy	NULL
's	NULL
5A	NULL
medium-10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum-2	NULL
mM	NULL
glutamine	NULL
.	NULL

Primary	NULL
cell	NULL
cultures	NULL
of	NULL
rat	NULL
type	NULL
I	NULL
astrocytes	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
from	NULL
the	NULL
cerebral	NULL
cortex	NULL
of	NULL
1-to	NULL
2-day-old	NULL
neonatal	NULL
Sprague-Dawley	NULL
rats	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
for	NULL
2	NULL
to	NULL
4	NULL
weeks	NULL
,	NULL
until	NULL
confluent	NULL
,	NULL
and	NULL
type	NULL
I	NULL
astrocytes	NULL
were	NULL
purified	NULL
by	NULL
a	NULL
regime	NULL
of	NULL
shaking	NULL
and	NULL
differential	NULL
adherence	NULL
to	NULL
flasks	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medi-um-10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum-2	NULL
mM	NULL
glutamine-100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml-100	NULL
mg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

Glioblastoma	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
500	NULL
U	NULL
of	NULL
recombinant	NULL
human	NULL
IFN-y	NULL
per	NULL
ml	NULL
,	NULL
which	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Biogen	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Transfection	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
was	NULL
performed	NULL
by	NULL
electroporation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Extracts	NULL
for	NULL
CAT	NULL
assays	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
transfected	NULL
cells	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
tested	NULL
for	NULL
CAT	NULL
activity	NULL
by	NULL
using	NULL
[	NULL
*HJacetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
genomic	NULL
footprinting	NULL
.	NULL

The	NULL
dimethyl	NULL
sulfate	NULL
treatment	NULL
of	NULL
cell	NULL
cultures	NULL
,	NULL
DNA	NULL
preparation	NULL
,	NULL
and	NULL
ligation-mediated	NULL
PCR	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
invariant	NULL
chain-specific	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
(	NULL
from	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
)	NULL
:	NULL
for	NULL
the	NULL
proximal	NULL
150	NULL
bp	NULL
,	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
,	NULL
primer	NULL
1	NULL
,	NULL
ATTGTTGGAGATAAGGTCA	NULL
;	NULL
primer	NULL
2	NULL
,	NULL
AT	NULL
GACTGGCTTCTGATCTTCCCGACAGC	NULL
;	NULL
primer	NULL
3	NULL
,	NULL
ACT	NULL
GGCTTCTGATCTTCCCGACAGCTCCTG	NULL
;	NULL
and	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
,	NULL
primer	NULL
1	NULL
,	NULL
GCCCAGAAA	NULL
CAAGTGATGAG	NULL
;	NULL
primer	NULL
2	NULL
,	NULL
GGATCGTGCTGGCCTTTC	NULL
TACCTGC	NULL
;	NULL
primer	NULL
3	NULL
,	NULL
GGATCGTGCTGGCCTTTCTACCT	NULL
GCCTG	NULL
;	NULL
for	NULL
the	NULL
distal	NULL
150	NULL
bp	NULL
,	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
,	NULL
primer	NULL
1	NULL
,	NULL
CTCTTAAAGTCGGTGCTG	NULL
;	NULL
primer	NULL
2	NULL
,	NULL
GCCACTCCGCCCACTTGGTAGATGTG	NULL
;	NULL
primer	NULL
3	NULL
,	NULL
CACTCCGCCCACTTGGTAGATGTGGAAGTG	NULL
;	NULL
and	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
,	NULL
primer	NULL
1	NULL
,	NULL
TGAGAAGGG	NULL
GAGACAAAC	NULL
;	NULL
primer	NULL
2	NULL
,	NULL
CAAAGTGCTTTCCTGTCTA	NULL
GGGAGTGGAC	NULL
;	NULL
primer	NULL
3	NULL
,	NULL
GTGCTTTCCTGTCTAGGG	NULL
AGTGGACATTITTGC	NULL
.	NULL

Nuclear	NULL
run-on	NULL
transcription	NULL
.	NULL

Nuclear	NULL
transcription	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
500	NULL
U	NULL
of	NULL
recombinant	NULL
human	NULL
IFN-y	NULL
for	NULL
0	NULL
,	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h	NULL
,	NULL
harvested	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
high-pH	NULL
buffer	NULL
with	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
washed	NULL
and	NULL
labeled	NULL
with	NULL
(	NULL
ICN	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

in	NULL
a	NULL
100-pul	NULL
reaction	NULL
for	NULL
15	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
labeled	NULL
nuclei	NULL
were	NULL
treated	NULL
with	NULL
DNase	NULL
,	NULL
extracted	NULL
with	NULL
hot	NULL
(	NULL
60°C	NULL
)	NULL
phenol-chloro-form-isoamyl	NULL
alcohol	NULL
(	NULL
1:1:0.01	NULL
)	NULL
,	NULL
and	NULL
concentrated	NULL
by	NULL
ethanol	NULL
precipitation	NULL
.	NULL

The	NULL
labeled	NULL
RNA	NULL
was	NULL
treated	NULL
with	NULL
0.2	NULL
M	NULL
NaOH	NULL
and	NULL
hybridized	NULL
to	NULL
DNA	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
at	NULL
40°C	NULL
.	NULL

The	NULL
hybridized	NULL
material	NULL
was	NULL
quantitated	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
EMSA	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
previously	NULL
described	NULL
method	NULL
(	NULL
7	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

The	NULL
cell	NULL
lysis	NULL
buffer	NULL
consisted	NULL
of	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
ethylene	NULL
glycol-bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
.N-N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
(	NULL
EGTA	NULL
)	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
(	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
E-64	NULL
)	NULL
.	NULL

NP-40	NULL
was	NULL
added	NULL
to	NULL
0.2	NULL
%	NULL
,	NULL
and	NULL
lysis	NULL
was	NULL
monitored	NULL
by	NULL
light	NULL
micros-copy	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
nuclear	NULL
extract	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
}	NULL
,	NULL
60	NULL
mM	NULL
NaCl	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
25	NULL
%	NULL
2928	NULL
BROWN	NULL
ET	NULL
AL	NULL
.	NULL

+261	NULL
-237	NULL
172	NULL
~118	NULL
-97	NULL
é	NULL
+	NULL
i	NULL
\	NULL
‘	NULL
``	NULL
“	NULL
s-ecaaacceces	NULL
§'-GGGGTATrch-37	NULL
3-CCCCTCGGGG-5	NULL
3-CCCCATAAAGG-5	NULL
'	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Ii	NULL
promoter	NULL
organization	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
the	NULL
Ii	NULL
promoter	NULL
from	NULL
-82	NULL
to	NULL
-261	NULL
bp	NULL
shows	NULL
the	NULL
Ii	NULL
regulatory	NULL
elements	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
regulatory	NULL
motifs	NULL
S	NULL
,	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
kB-1	NULL
,	NULL
kB-2	NULL
,	NULL
and	NULL
ISRE	NULL
are	NULL
in	NULL
shaded	NULL
boxes	NULL
.	NULL

glycerol	NULL
,	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

NaCl	NULL
(	NULL
5	NULL
M	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
*°P	NULL
labeled	NULL
and	NULL
annealed	NULL
oligonucleotides	NULL
that	NULL
contain	NULL
the	NULL
following	NULL
sequence	NULL
:	NULL
5'-AGCTTGGGGTATTTCCAGCCG-3	NULL
'	NULL
(	NULL
Ii	NULL
«	NULL
kB-1	NULL
)	NULL
and	NULL
5'-AGCTTGGGGGAGCCCCG-3	NULL
'	NULL
(	NULL
Ii	NULL
kB-2	NULL
)	NULL
(	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
printed	NULL
in	NULL
boldface	NULL
type	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
proteins	NULL
were	NULL
previously	NULL
described	NULL
[	NULL
anti-p65	NULL
(	NULL
7	NULL
)	NULL
,	NULL
anti-52	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
M.	NULL
Karin	NULL
)	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
(	NULL
43	NULL
)	NULL
]	NULL
;	NULL
anti-NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
NLS	NULL
)	NULL
was	NULL
purchased	NULL
and	NULL
used	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
bacterially	NULL
expressed	NULL
IxBa	NULL
was	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Amer	NULL
Beg	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
contained	NULL
5	NULL
to	NULL
10	NULL
mg	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
75	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
%	NULL
Ficoll	NULL
,	NULL
0.5	NULL
mM	NULL
phenyImethyl-sulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
0.1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
wl	NULL
.	NULL

Antibodies	NULL
and	NULL
IxB	NULL
protein	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
or	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
Tris-glycine	NULL
buffer	NULL
.	NULL

RESULTS	NULL
Protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
vivo	NULL
genomic	NULL
footprinting	NULL
is	NULL
a	NULL
powerful	NULL
approach	NULL
that	NULL
examines	NULL
the	NULL
occupancy	NULL
of	NULL
DNA	NULL
regulatory	NULL
elements	NULL
by	NULL
transcription	NULL
factors	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

A	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
functional	NULL
regulatory	NULL
units	NULL
in	NULL
promoters	NULL
of	NULL
expressed	NULL
genes	NULL
are	NULL
bound	NULL
in	NULL
vivo	NULL
(	NULL
5	NULL
,	NULL
16	NULL
,	NULL
27	NULL
,	NULL
33	NULL
,	NULL
36	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
analyses	NULL
by	NULL
genomic	NULL
footprinting	NULL
have	NULL
revealed	NULL
that	NULL
the	NULL
in	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Ii	NULL
regulatory	NULL
elements	NULL
X	NULL
and	NULL
Y	NULL
correlate	NULL
precisely	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Ii	NULL
gene	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
in	NULL
vivo	NULL
protein	NULL
binding	NULL
at	NULL
two	NULL
Ii	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
binding	NULL
sites	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
nonexpressing	NULL
T-cell	NULL
lines	NULL
,	NULL
the	NULL
li-positive	NULL
T-cell	NULL
line	NULL
H9	NULL
,	NULL
and	NULL
IFN-y-induced	NULL
and	NULL
uninduced	NULL
glioblastoma	NULL
cells	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
xB/Re	NULL
!	NULL

site	NULL
proximal	NULL
to	NULL
the	NULL
Ii	NULL
transcription	NULL
start	NULL
at	NULL
sequence	NULL
-109	NULL
to	NULL
-118	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
Ii	NULL
kB-1	NULL
,	NULL
and	NULL
the	NULL
distal	NULL
site	NULL
at	NULL
sequence	NULL
-163	NULL
to	NULL
-172	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
Ii	NULL
xkB-2	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
dimethyl	NULL
sulfate	NULL
footprinting	NULL
.	NULL

Proteins	NULL
contacted	NULL
G	NULL
residues	NULL
in	NULL
the	NULL
Ii	NULL
kB-1	NULL
element	NULL
in	NULL
the	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
top	NULL
panel	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
in	NULL
H9	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
Ii-negative	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Another	NULL
Ti-positive	NULL
B-cell	NULL
line	NULL
,	NULL
Namalwa	NULL
,	NULL
and	NULL
another	NULL
negative	NULL
T-cell	NULL
line	NULL
,	NULL
HSB	NULL
,	NULL
gave	NULL
identical	NULL
results	NULL
to	NULL
the	NULL
Raji	NULL
and	NULL
Jurkat	NULL
lines	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
Mor	NULL
.	NULL

CEL	NULL
.	NULL

BioL	NULL
.	NULL

Raji	NULL
_	NULL
_	NULL
__	NULL
H9	NULL
_	NULL
Jurkat	NULL
Con	NULL
DMS	NULL
»	NULL
SNe	NULL
witn	NULL
-	NULL
ume	NULL
mas	NULL
whish	NULL
e	NULL
#	NULL
No	NULL
m	NULL
&	NULL
a	NULL
#	NULL
w-	NULL
Gz	NULL
0	NULL
.	NULL

6	NULL
&	NULL
9	NULL
10	NULL
11	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

In	NULL
vivo	NULL
genomic	NULL
footprint	NULL
of	NULL
Ii	NULL
NF-xB/Re	NULL
!	NULL

binding	NULL
sites	NULL
.	NULL

Footprint	NULL
of	NULL
the	NULL
Ii	NULL
kB	NULL
sites	NULL
in	NULL
the	NULL
region	NULL
from	NULL
-98	NULL
to	NULL
-147	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
-141	NULL
to	NULL
-182	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
of	NULL
the	NULL
Ii	NULL
promoter	NULL
with	NULL
DNA	NULL
from	NULL
Raji	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
H9	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
IFN-y-treated	NULL
U-105	NULL
MG	NULL
at	NULL
0	NULL
,	NULL
4	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
11	NULL
)	NULL
.	NULL

A	NULL
footprint	NULL
of	NULL
the	NULL
region	NULL
surrounding	NULL
each	NULL
NF-kB/Rel	NULL
homolog	NULL
and	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
each	NULL
NF-	NULL
B/Rel	NULL
site	NULL
are	NULL
shown	NULL
.	NULL

Lanes	NULL
Con	NULL
and	NULL
DMS	NULL
are	NULL
DNA	NULL
methylated	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
respectively	NULL
.	NULL

Open	NULL
circles	NULL
mark	NULL
positions	NULL
of	NULL
protections	NULL
,	NULL
and	NULL
solid	NULL
circles	NULL
mark	NULL
positions	NULL
of	NULL
enhancements	NULL
.	NULL

observations	NULL
indicate	NULL
that	NULL
the	NULL
in	NULL
vivo	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
segregates	NULL
with	NULL
expression	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
and	NULL
implicates	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
element	NULL
in	NULL
Ii	NULL
gene	NULL
regulation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
constitutive	NULL
mode	NULL
of	NULL
Ii	NULL
expression	NULL
,	NULL
the	NULL
occupancy	NULL
of	NULL
the	NULL
Ii	NULL
site	NULL
was	NULL
also	NULL
examined	NULL
upon	NULL
induction	NULL
by	NULL
IFN-y	NULL
in	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
U-105	NULL
MG.	NULL
Ii	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
is	NULL
inducible	NULL
to	NULL
high	NULL
levels	NULL
over	NULL
basal	NULL
expression	NULL
by	NULL
IFN-y	NULL
.	NULL

The	NULL
Ii	NULL
element	NULL
was	NULL
unbound	NULL
in	NULL
uninduced	NULL
U-105	NULL
MG	NULL
glioblastoma	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
top	NULL
panel	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
after	NULL
IFN-y	NULL
treatment	NULL
,	NULL
a	NULL
pattern	NULL
of	NULL
protections	NULL
and	NULL
an	NULL
enhancement	NULL
appear	NULL
over	NULL
the	NULL
Ii	NULL
xkB-1	NULL
site	NULL
in	NULL
the	NULL
glioblastoma	NULL
cells	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
11	NULL
)	NULL
.	NULL

These	NULL
bands	NULL
become	NULL
most	NULL
intense	NULL
by	NULL
48	NULL
h	NULL
,	NULL
whereupon	NULL
the	NULL
pattern	NULL
resembled	NULL
the	NULL
pattern	NULL
observed	NULL
on	NULL
Ii	NULL
in	NULL
Raji	NULL
and	NULL
H9	NULL
cells	NULL
.	NULL

Ii	NULL
kB-2	NULL
had	NULL
no	NULL
detectable	NULL
protein	NULL
contacts	NULL
in	NULL
Raji	NULL
cells	NULL
,	NULL
Jurkat	NULL
cells	NULL
,	NULL
or	NULL
U-105	NULL
MG	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
pronounced	NULL
binding	NULL
was	NULL
detected	NULL
on	NULL
Ii	NULL
kB-2	NULL
in	NULL
H9	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
recent	NULL
findings	NULL
show	NULL
in	NULL
vitro	NULL
binding	NULL
to	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
kB	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
H9	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Ii	NULL
NF-xB/Re	NULL
!	NULL

elements	NULL
have	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
activity	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
.	NULL

NF-	NULL
«	NULL
kB/Rel	NULL
binding	NULL
sites	NULL
control	NULL
transcription	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
immune	NULL
response	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
genomic	NULL
footprinting	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
Ii	NULL
NF-kB/Re	NULL
!	NULL

sites	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
Ii	NULL
gene	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
Ii	NULL
kB-1	NULL
and	NULL
Ii	NULL
kB-2	NULL
,	NULL
the	NULL
two	NULL
sites	NULL
were	NULL
individually	NULL
mutated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-	NULL
790	NULL
Ii	NULL
promoter	NULL
region	NULL
(	NULL
7901iCAT	NULL
plasmid	NULL
)	NULL
and	NULL
the	NULL
promoter-CAT	NULL
constructs	NULL
were	NULL
designated	NULL
Mut	NULL
kB-1	NULL
and	NULL
Mut	NULL
kB-2	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
cell	NULL
lines	NULL
representing	NULL
various	NULL
cell	NULL
types	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
each	NULL
mutant	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
wild-type	NULL
(	NULL
790IiCAT	NULL
)	NULL
construct	NULL
.	NULL

Analysis	NULL
by	NULL
transfection	NULL
into	NULL
Ii-expressing	NULL
Raji	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
was	NULL
straightforward	NULL
and	NULL
showed	NULL
that	NULL
mutation	NULL
of	NULL
Ii	NULL
<	NULL
B-1	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
transcription	NULL
to	NULL
44	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
whereas	NULL
mutation	NULL
at	NULL
Ii	NULL
kB-2	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
53	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
both	NULL
sites	NULL
resulted	NULL
in	NULL
28	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
81	NULL
I	NULL
Raji	NULL
8.0	NULL
Z	NULL
Ho	NULL
3g	NULL
,	NULL
'-	NULL
:	NULL
R	NULL
Jurkat	NULL
a	NULL
R	NULL
[	NULL
ves	NULL
?	NULL

g	NULL
3.0-	NULL
g	NULL
<	NULL
as	NULL
.	NULL

If	NULL
3	NULL
A	NULL
``	NULL
#	NULL
1.0	NULL
<	NULL
é	NULL
0.5	NULL
<	NULL
Z	NULL
Mut	NULL
xB-1	NULL
Wild	NULL
Typ	NULL
Mut	NULL
xB-2	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Ii	NULL
xB-1	NULL
and	NULL
Ii	NULL
xB-2	NULL
have	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
functions	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
.	NULL

Transient-transfection	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
plasmids	NULL
containing	NULL
wild-type	NULL
Ii	NULL
promoter	NULL
and	NULL
Ii	NULL
promoter	NULL
with	NULL
mutant	NULL
Ii	NULL
xB	NULL
sites	NULL
in	NULL
Raji	NULL
,	NULL
H9	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

Raji	NULL
,	NULL
H9	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
each	NULL
plasmid	NULL
DNA	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
8	NULL
g	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
mean	NULL
CAT	NULL
activity	NULL
obtained	NULL
for	NULL
each	NULL
mutant	NULL
(	NULL
n	NULL
>	NULL
5	NULL
)	NULL
is	NULL
normalized	NULL
to	NULL
that	NULL
obtained	NULL
for	NULL
the	NULL
wild-type	NULL
plasmid	NULL
(	NULL
790IiCAT	NULL
)	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
as	NULL
100	NULL
%	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
mean	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
construct	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
Raji	NULL
,	NULL
130,158	NULL
cpm	NULL
;	NULL
H9	NULL
,	NULL
222,813	NULL
cpm	NULL
;	NULL
Jurkat	NULL
,	NULL
26,178	NULL
cpm	NULL
;	NULL
and	NULL
U937	NULL
,	NULL
3,591	NULL
cpm	NULL
.	NULL

shown	NULL
)	NULL
.	NULL

When	NULL
assayed	NULL
in	NULL
Namalwa	NULL
,	NULL
another	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
whereas	NULL
in	NULL
vivo	NULL
occupancy	NULL
of	NULL
Ii	NULL
kB-1	NULL
in	NULL
Raji	NULL
cells	NULL
was	NULL
clearly	NULL
demon-strated	NULL
,	NULL
Ti	NULL
kB-2	NULL
occupancy	NULL
was	NULL
not	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
bottom	NULL
panel	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
protein	NULL
binding	NULL
occurs	NULL
at	NULL
this	NULL
site	NULL
but	NULL
escapes	NULL
detection	NULL
because	NULL
of	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
assay	NULL
or	NULL
the	NULL
protein-DNA	NULL
interaction	NULL
;	NULL
this	NULL
topic	NULL
is	NULL
discussed	NULL
in	NULL
more	NULL
detail	NULL
below	NULL
(	NULL
see	NULL
the	NULL
discussion	NULL
of	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
classical	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
elements	NULL
,	NULL
S	NULL
,	NULL
X	NULL
,	NULL
and	NULL
Y	NULL
(	NULL
12	NULL
)	NULL
,	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
sites	NULL
contribute	NULL
to	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
Ii	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Although	NULL
most	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
the	NULL
Ii	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
,	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

BINDING	NULL
SITES	NULL
IN	NULL
MHC	NULL
CLASS	NULL
II	NULL
Ii	NULL
PROMOTER	NULL
2929	NULL
H9	NULL
(	NULL
HUT78	NULL
)	NULL
do	NULL
express	NULL
these	NULL
genes	NULL
.	NULL

Mutation	NULL
of	NULL
Ii	NULL
«	NULL
kB-1	NULL
reduced	NULL
CAT	NULL
activity	NULL
in	NULL
transfected	NULL
H9	NULL
cells	NULL
to	NULL
61	NULL
%	NULL
of	NULL
control	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
when	NULL
a	NULL
more	NULL
conservative	NULL
Ii	NULL
kB-1	NULL
mutation	NULL
(	NULL
kB-1m3	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Unexpectedly	NULL
,	NULL
when	NULL
Ii	NULL
<	NULL
B-2	NULL
was	NULL
analyzed	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
increased	NULL
threefold	NULL
over	NULL
wild-type	NULL
levels	NULL
by	NULL
mutating	NULL
this	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
occupancy	NULL
of	NULL
this	NULL
site	NULL
was	NULL
unique	NULL
to	NULL
H9	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
in	NULL
the	NULL
H9	NULL
T	NULL
cells	NULL
,	NULL
Ii	NULL
xB-1	NULL
and	NULL
Ii	NULL
<	NULL
B-2	NULL
appear	NULL
to	NULL
be	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
sites	NULL
are	NULL
occupied	NULL
in	NULL
vivo	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
Ii-negative	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
revealed	NULL
no	NULL
function	NULL
for	NULL
Ii	NULL
sites	NULL
in	NULL
Ii	NULL
gene	NULL
promoter	NULL
regulation	NULL
since	NULL
mutation	NULL
of	NULL
either	NULL
site	NULL
did	NULL
not	NULL
significantly	NULL
change	NULL
basal	NULL
levels	NULL
of	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
agree	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
in	NULL
vivo	NULL
binding	NULL
over	NULL
these	NULL
sites	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
are	NULL
expected	NULL
because	NULL
NF-KB	NULL
is	NULL
cytoplasmic	NULL
in	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

When	NULL
these	NULL
cells	NULL
are	NULL
stimulated	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

To	NULL
broadly	NULL
ascertain	NULL
the	NULL
function	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
,	NULL
we	NULL
examined	NULL
several	NULL
other	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
the	NULL
human	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
the	NULL
murine	NULL
myelomonocytic	NULL
line	NULL
WEHI-3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
the	NULL
human	NULL
cervical	NULL
carcinoma	NULL
line	NULL
HeLa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
Ii	NULL
«	NULL
kB-1-binding	NULL
site	NULL
resulted	NULL
in	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
transcriptional	NULL
activity	NULL
and	NULL
typically	NULL
increased	NULL
promoter	NULL
activity	NULL
by	NULL
8-	NULL
to	NULL
10-fold	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
as	NULL
in	NULL
the	NULL
H9	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
Ii	NULL
kB-2	NULL
increased	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
Ii	NULL
«	NULL
B-1	NULL
contributes	NULL
to	NULL
basal	NULL
activation	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
H9	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
basal	NULL
repression	NULL
in	NULL
epithe-lial	NULL
and	NULL
monocytic	NULL
cell	NULL
types	NULL
.	NULL

Ii	NULL
xB-2	NULL
functions	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
H9	NULL
cells	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
(	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mutation	NULL
of	NULL
Ii	NULL
<	NULL
kB-1	NULL
and	NULL
on	NULL
Ii	NULL
induction	NULL
by	NULL
IFN-y	NULL
in	NULL
glioblastoma	NULL
U-105	NULL
MG	NULL
cells	NULL
was	NULL
also	NULL
examined	NULL
.	NULL

The	NULL
Ii	NULL
S	NULL
,	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
ISRE	NULL
are	NULL
required	NULL
for	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
Ii	NULL
gene	NULL
in	NULL
U-105	NULL
MG	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
11	NULL
)	NULL
.	NULL

We	NULL
were	NULL
therefore	NULL
interested	NULL
in	NULL
whether	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
sites	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
IFN-y	NULL
response	NULL
.	NULL

When	NULL
absolute	NULL
values	NULL
were	NULL
compared	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
Ii	NULL
kB-1	NULL
or	NULL
Ii	NULL
<	NULL
kB-2	NULL
produced	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
relative	NULL
CAT	NULL
activity	NULL
for	NULL
both	NULL
basal	NULL
levels	NULL
and	NULL
IFN-y-induced	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
Ii	NULL
gene	NULL
expression	NULL
indicates	NULL
that	NULL
the	NULL
Ii	NULL
binding	NULL
sites	NULL
have	NULL
a	NULL
negative	NULL
effect	NULL
on	NULL
basal	NULL
transcription	NULL
in	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
.	NULL

Since	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
change	NULL
in	NULL
fold	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
two	NULL
NF-kB/Rel	NULL
sites	NULL
are	NULL
not	NULL
necessary	NULL
for	NULL
IFN-y	NULL
regulation	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
Ii	NULL
S	NULL
,	NULL
X	NULL
,	NULL
and	NULL
Y	NULL
elements	NULL
,	NULL
TABLE	NULL
1	NULL
.	NULL

Summary	NULL
of	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
activities	NULL
Presence	NULL
of	NULL
antibody	NULL
supershifted	NULL
complex	NULL
``	NULL
kB	NULL
site	NULL
Cell	NULL
line	NULL
Transcrigtiozlal	NULL
In	NULL
vivo	NULL
a-p65	NULL
a-p52	NULL
regulation	NULL
occupancy	NULL
«	NULL
B-1	NULL
Raji	NULL
+	NULL
++	NULL
++	NULL
++	NULL
A	NULL
+	NULL
H9	NULL
+	NULL
+++	NULL
++	NULL
-	NULL
A	NULL
+	NULL
U937	NULL
-	NULL
+	NULL
-	NULL
-	NULL
R	NULL
ND®	NULL
U105-MG	NULL
-	NULL
-	NULL
-	NULL
-	NULL
R	NULL
_	NULL
a	NULL
kB-2	NULL
Raji	NULL
+	NULL
+++	NULL
++	NULL
++	NULL
A	NULL
H9	NULL
-	NULL
+++	NULL
++	NULL
-	NULL
R	NULL
+	NULL
U937	NULL
-	NULL
++	NULL
-	NULL
-	NULL
R	NULL
ND	NULL
U105-MG	NULL
-	NULL
+	NULL
-	NULL
_-	NULL
R	NULL
_	NULL
``	NULL
«	NULL
indicates	NULL
``	NULL
anti	NULL
.	NULL
``	NULL

®	NULL
A	NULL
,	NULL
activation	NULL
;	NULL
R	NULL
,	NULL
repression	NULL
.	NULL

©	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

4	NULL
In	NULL
vivo	NULL
occupancy	NULL
at	NULL
this	NULL
site	NULL
was	NULL
observed	NULL
upon	NULL
induction	NULL
with	NULL
IFN-y	NULL
.	NULL

2930	NULL
BROWN	NULL
ET	NULL
AL	NULL
.	NULL

160	NULL
120-	NULL
31	NULL
%	NULL
a	NULL
3	NULL
0	NULL
<	NULL
4	NULL
<	NULL
4	NULL
80	NULL
0	NULL
@	NULL
2	NULL
3	NULL
]	NULL
©	NULL
(	NULL
3	NULL
30X	NULL
40	NULL
0	NULL
1	NULL
30	NULL
3	NULL
93	NULL
5	NULL
113	NULL
wild	NULL
type	NULL
txB-	NULL
B-2	NULL
liCAT	NULL
Mut	NULL
xB-1	NULL
Mut	NULL
x	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
mutation	NULL
of	NULL
Ii	NULL
kB-1	NULL
and	NULL
Ii	NULL
kB-2	NULL
on	NULL
basal	NULL
and	NULL
IFN-y-induced	NULL
expression	NULL
in	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
U-105	NULL
MG	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
plasmids	NULL
and	NULL
treated	NULL
with	NULL
IFN-y	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
at	NULL
48	NULL
h	NULL
after	NULL
treatment	NULL
.	NULL

The	NULL
means	NULL
of	NULL
the	NULL
relative	NULL
CAT	NULL
activities	NULL
for	NULL
each	NULL
sample	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
bars	NULL
(	NULL
#	NULL
=	NULL
8	NULL
)	NULL
.	NULL

They	NULL
have	NULL
been	NULL
normalized	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
construct	NULL
(	NULL
790I1CAT/no	NULL
IFN-y	NULL
equals	NULL
1.0	NULL
)	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
for	NULL
each	NULL
plasmid	NULL
is	NULL
shown	NULL
above	NULL
the	NULL
bar	NULL
representing	NULL
the	NULL
IFN-y-induced	NULL
values	NULL
.	NULL

The	NULL
solid	NULL
and	NULL
shaded	NULL
bars	NULL
represent	NULL
basal	NULL
and	NULL
IFN-y-induced	NULL
expression	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

which	NULL
are	NULL
all	NULL
required	NULL
for	NULL
IFN-y-inducible	NULL
transcription	NULL
in	NULL
U-105	NULL
MG	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
strong	NULL
derepression	NULL
of	NULL
basal	NULL
transcription	NULL
was	NULL
observed	NULL
when	NULL
Mut	NULL
<	NULL
B-1	NULL
was	NULL
transfected	NULL
into	NULL
CRT	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
astrocytoma	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
into	NULL
primary	NULL
untransformed	NULL
rat	NULL
astrocyte	NULL
cultures	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
sites	NULL
also	NULL
have	NULL
silencing	NULL
functions	NULL
in	NULL
transformed	NULL
and	NULL
primary	NULL
brain	NULL
glial	NULL
cells	NULL
.	NULL

One	NULL
curious	NULL
observation	NULL
is	NULL
that	NULL
the	NULL
Ii	NULL
kB-1	NULL
element	NULL
is	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
IFN-y-treated	NULL
glioblastoma	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
,	NULL
becomes	NULL
bound	NULL
upon	NULL
IFN-y	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
top	NULL
panel	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
11	NULL
)	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
at	NULL
this	NULL
site	NULL
is	NULL
involved	NULL
in	NULL
repression	NULL
during	NULL
induction	NULL
.	NULL

Conceivably	NULL
this	NULL
repression	NULL
occurs	NULL
after	NULL
activation	NULL
because	NULL
the	NULL
enhancement	NULL
and	NULL
the	NULL
protections	NULL
at	NULL
Ii	NULL
kB-1	NULL
are	NULL
most	NULL
intense	NULL
at	NULL
48	NULL
h	NULL
after	NULL
IFN-y	NULL
treatment	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
whereas	NULL
IFN-y-inducible	NULL
binding	NULL
at	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
ISRE	NULL
is	NULL
maximal	NULL
by	NULL
24	NULL
h	NULL
(	NULL
11	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
timing	NULL
of	NULL
this	NULL
interaction	NULL
indicates	NULL
that	NULL
after	NULL
transcription	NULL
is	NULL
induced	NULL
,	NULL
a	NULL
protein	NULL
interaction	NULL
that	NULL
leads	NULL
to	NULL
down-regulation	NULL
is	NULL
completed	NULL
at	NULL
the	NULL
Ii	NULL
«	NULL
kB-1	NULL
site	NULL
.	NULL

To	NULL
study	NULL
this	NULL
further	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
at	NULL
0	NULL
,	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h	NULL
after	NULL
IFN-y	NULL
treatment	NULL
in	NULL
a	NULL
run-on	NULL
transcription	NULL
experiment	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
Ii	NULL
transcription	NULL
increases	NULL
up	NULL
to	NULL
24	NULL
h	NULL
,	NULL
plateaus	NULL
at	NULL
24	NULL
to	NULL
48	NULL
h	NULL
,	NULL
and	NULL
finally	NULL
returns	NULL
to	NULL
near	NULL
basal	NULL
levels	NULL
by	NULL
72	NULL
h.	NULL
The	NULL
timing	NULL
of	NULL
down-regulated	NULL
de	NULL
novo	NULL
Ii	NULL
mRNA	NULL
synthesis	NULL
immediately	NULL
follows	NULL
the	NULL
timing	NULL
of	NULL
protein	NULL
binding	NULL
in	NULL
vivo	NULL
at	NULL
Ii	NULL
«	NULL
B-1	NULL
.	NULL

Thus	NULL
changes	NULL
in	NULL
in	NULL
vivo	NULL
occupancy	NULL
at	NULL
this	NULL
site	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
repressor	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

To	NULL
show	NULL
that	NULL
the	NULL
Ii	NULL
kB-1	NULL
mutation	NULL
did	NULL
not	NULL
create	NULL
a	NULL
new	NULL
regulatory	NULL
site	NULL
,	NULL
we	NULL
tested	NULL
another	NULL
mutant	NULL
plasmid	NULL
,	NULL
«	NULL
B-1m3	NULL
,	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

xB-1m3	NULL
is	NULL
a	NULL
more	NULL
conservative	NULL
mutation	NULL
in	NULL
which	NULL
described	NULL
NF-kB	NULL
contact	NULL
points	NULL
(	NULL
the	NULL
first	NULL
three	NULL
G	NULL
residues	NULL
)	NULL
were	NULL
mutated	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Results	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
caimime	NULL
«	NULL
atm	NULL
=	NULL
invariant	NULL
cyclophilin	NULL
0	NULL
24	NULL
48	NULL
72	NULL
B	NULL
e	NULL
a	NULL
--	NULL
§	NULL
,	NULL
]	NULL
]	NULL
\	NULL
25	NULL
]	NULL
-	NULL
/	NULL
\	NULL
i-	NULL
{	NULL
/	NULL
c	NULL
~*~	NULL
invariant	NULL
chain	NULL
8	NULL
e-	NULL
/	NULL
X	NULL
|	NULL
&	NULL
/	NULL
\	NULL
|	NULL
-	NULL
#	NULL
-	NULL
lophili	NULL
£	NULL
~*~	NULL
cyclophilin	NULL
-	NULL
“	NULL
j	NULL
/	NULL
\	NULL
yclop	NULL
3	NULL
£	NULL
1	NULL
2/	NULL
|	NULL
@	NULL
-	NULL
{	NULL
--	NULL
-	NULL
R	NULL
4	NULL
e	NULL
0	NULL
24	NULL
48	NULL
72	NULL
Hours	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Rate	NULL
of	NULL
transcription	NULL
of	NULL
Ii	NULL
after	NULL
IFN-y	NULL
induction	NULL
in	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
,	NULL
U-105	NULL
MG	NULL
.	NULL

The	NULL
glioblastoma	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
for	NULL
0	NULL
,	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h.	NULL
Nascent	NULL
mRNA	NULL
was	NULL
radiolabeled	NULL
in	NULL
vivo	NULL
and	NULL
hybridized	NULL
to	NULL
immobilized	NULL
Ii	NULL
or	NULL
cyclophilin	NULL
DNA	NULL
as	NULL
a	NULL
control	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Results	NULL
monitored	NULL
by	NULL
the	NULL
PhosphorImager	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Values	NULL
normalized	NULL
relative	NULL
to	NULL
the	NULL
cyclophilin	NULL
control	NULL
and	NULL
plotted	NULL
for	NULL
each	NULL
time	NULL
point	NULL
.	NULL

of	NULL
CAT	NULL
assays	NULL
in	NULL
Raji	NULL
,	NULL
H9	NULL
,	NULL
and	NULL
U-105	NULL
MG	NULL
cells	NULL
revealed	NULL
that	NULL
had	NULL
similar	NULL
transcriptional	NULL
activity	NULL
to	NULL
that	NULL
of	NULL
Mut	NULL
kB-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
two	NULL
independent	NULL
mutations	NULL
of	NULL
Ii	NULL
kB-1	NULL
resulted	NULL
in	NULL
similar	NULL
changes	NULL
in	NULL
Ii	NULL
basal	NULL
expression	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
Mut	NULL
kB-1	NULL
created	NULL
another	NULL
regulatory	NULL
site	NULL
for	NULL
an	NULL
activator	NULL
or	NULL
inhibitor	NULL
protein	NULL
.	NULL

Ii	NULL
<	NULL
B-2	NULL
silencer	NULL
acts	NULL
in	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
but	NULL
Ii	NULL
does	NULL
not	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
two	NULL
Ii	NULL
NF-kB/Re	NULL
!	NULL

sites	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
non-Ii	NULL
promoter	NULL
,	NULL
we	NULL
made	NULL
CAT	NULL
reporter	NULL
constructs	NULL
with	NULL
one	NULL
of	NULL
either	NULL
site	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
.	NULL

These	NULL
reporter	NULL
plasmids	NULL
were	NULL
tested	NULL
by	NULL
transfection	NULL
and	NULL
CAT	NULL
assay	NULL
in	NULL
3.0	NULL
2.5	NULL
2.0	NULL
1.57	NULL
1.07	NULL
Relative	NULL
CAT	NULL
Activity	NULL
0.5	NULL
0.0	NULL
TKCAT	NULL
-	NULL
«	NULL
xB-1TKCAT	NULL
«	NULL
B-2TKCAT	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
Ii	NULL
kB	NULL
sites	NULL
on	NULL
the	NULL
TK	NULL
promoter	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
8	NULL
pg	NULL
of	NULL
the	NULL
indicated	NULL
plasmid	NULL
.	NULL

The	NULL
constructs	NULL
are	NULL
the	NULL
TK	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
alone	NULL
(	NULL
TKCAT	NULL
)	NULL
,	NULL
the	NULL
Ii	NULL
kB-1	NULL
linked	NULL
to	NULL
the	NULL
TKCAT	NULL
(	NULL
«	NULL
B-1TKCAT	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Ii	NULL
xB-2	NULL
site	NULL
linked	NULL
to	NULL
the	NULL
TKCAT	NULL
plasmid	NULL
(	NULL
«	NULL
B-2TKCAT	NULL
)	NULL
.	NULL

At	NULL
36	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
mean	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
three	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
U937	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
both	NULL
sites	NULL
have	NULL
a	NULL
negative	NULL
effect	NULL
on	NULL
Ii	NULL
gene	NULL
transcription	NULL
within	NULL
the	NULL
context	NULL
of	NULL
its	NULL
own	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

kB-1TKCAT	NULL
produced	NULL
slightly	NULL
increased	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
TKCAT	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Ii	NULL
exhibited	NULL
a	NULL
strong	NULL
negative	NULL
effect	NULL
on	NULL
the	NULL
TK	NULL
promoter	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
complete	NULL
loss	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

These	NULL
experiments	NULL
suggest	NULL
that	NULL
Ii	NULL
xkB-1	NULL
may	NULL
be	NULL
a	NULL
position-	NULL
or	NULL
context-dependent	NULL
silencer	NULL
and	NULL
that	NULL
Ii	NULL
is	NULL
a	NULL
silencer	NULL
able	NULL
to	NULL
function	NULL
outside	NULL
the	NULL
context	NULL
of	NULL
the	NULL
Ii	NULL
promoter	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
at	NULL
Ii	NULL
NF-KB	NULL
elements	NULL
and	NULL
identification	NULL
of	NULL
NF-	NULL
<	NULL
B/Rel	NULL
protein	NULL
subunits	NULL
.	NULL

We	NULL
considered	NULL
it	NULL
likely	NULL
that	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
effects	NULL
of	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
were	NULL
due	NULL
to	NULL
differential	NULL
expression	NULL
or	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
39	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
,	NULL
H9	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
by	NULL
EMSA	NULL
and	NULL
discovered	NULL
differences	NULL
in	NULL
the	NULL
protein	NULL
complexes	NULL
bound	NULL
by	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
probes	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

Figure	NULL
7	NULL
shows	NULL
protein	NULL
complexes	NULL
on	NULL
Ii	NULL
xB-1	NULL
and	NULL
Ii	NULL
xB-2	NULL
probes	NULL
in	NULL
Raji	NULL
,	NULL
H9	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
;	NULL
the	NULL
relatedness	NULL
of	NULL
the	NULL
complexes	NULL
is	NULL
demonstrated	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
Ii	NULL
xB-1	NULL
and	NULL
«	NULL
B-2	NULL
oligonucleotides	NULL
.	NULL

Raji	NULL
nuclear	NULL
extracts	NULL
formed	NULL
four	NULL
complexes	NULL
with	NULL
Ii	NULL
xkB-1	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
and	NULL
three	NULL
distinct	NULL
complexes	NULL
with	NULL
Ii	NULL
«	NULL
B-2	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

H9	NULL
extracts	NULL
formed	NULL
six	NULL
bands	NULL
with	NULL
Ii	NULL
kB-1	NULL
(	NULL
doublets	NULL
are	NULL
resolved	NULL
upon	NULL
shorter	NULL
exposures	NULL
of	NULL
the	NULL
gel	NULL
;	NULL
also	NULL
see	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
and	NULL
two	NULL
bands	NULL
with	NULL
Ii	NULL
«	NULL
kB-2	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

U937	NULL
extracts	NULL
formed	NULL
two	NULL
complexes	NULL
with	NULL
the	NULL
Ii	NULL
kB-1	NULL
probe	NULL
and	NULL
one	NULL
complex	NULL
with	NULL
the	NULL
Ii	NULL
xB-2	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
complexes	NULL
were	NULL
specific	NULL
as	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
homologous	NULL
as	NULL
well	NULL
as	NULL
unrelated	NULL
oligonucleotide	NULL
sequences	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
each	NULL
set	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
is	NULL
different	NULL
;	NULL
although	NULL
some	NULL
bands	NULL
seem	NULL
to	NULL
have	NULL
identical	NULL
migration	NULL
,	NULL
other	NULL
bands	NULL
are	NULL
unique	NULL
for	NULL
the	NULL
corresponding	NULL
extract	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
each	NULL
Ii	NULL
NF-kB/Rel	NULL
site	NULL
appears	NULL
to	NULL
bind	NULL
a	NULL
different	NULL
pattern	NULL
of	NULL
complexes	NULL
in	NULL
each	NULL
cell	NULL
type	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
Ii	NULL
kB-1	NULL
site	NULL
to	NULL
bind	NULL
cloned	NULL
recombinant	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
that	NULL
had	NULL
been	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
or	NULL
in	NULL
vitro	NULL
translation	NULL
systems	NULL
.	NULL

The	NULL
Ii	NULL
xB-1	NULL
probe	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
p65	NULL
and	NULL
p50	NULL
in	NULL
the	NULL
EMSA	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
that	NULL
of	NULL
complexes	NULL
formed	NULL
on	NULL
an	NULL
HIV-	NULL
«	NULL
kB	NULL
probe	NULL
,	NULL
whereas	NULL
extracts	NULL
containing	NULL
expression	NULL
vector	NULL
alone	NULL
were	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
Ti	NULL
xB-1	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
these	NULL
combinations	NULL
if	NULL
they	NULL
present	NULL
.	NULL

We	NULL
were	NULL
also	NULL
interested	NULL
in	NULL
which	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
members	NULL
composed	NULL
the	NULL
different	NULL
protein-DNA	NULL
complexes	NULL
on	NULL
activator	NULL
compared	NULL
with	NULL
repressor	NULL
sites	NULL
in	NULL
the	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
Ii	NULL
sites	NULL
,	NULL
we	NULL
used	NULL
specific	NULL
antibodies	NULL
in	NULL
EMSA	NULL
to	NULL
identify	NULL
known	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
proteins	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
for	NULL
a	NULL
summary	NULL
of	NULL
the	NULL
data	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
antibody-treated	NULL
and	NULL
untreated	NULL
reactions	NULL
with	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
and	NULL
Ii	NULL
xB-1	NULL
shows	NULL
that	NULL
anti-p65	NULL
caused	NULL
a	NULL
weak	NULL
supershifted	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
addition	NULL
of	NULL
the	NULL
peptide	NULL
to	NULL
which	NULL
the	NULL
antiserum	NULL
was	NULL
made	NULL
abolished	NULL
this	NULL
complex	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
anti-p65	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
can	NULL
effectively	NULL
shift	NULL
a	NULL
TNF-	NULL
«	NULL
-induced	NULL
complex	NULL
in	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
7	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
weak	NULL
supershift	NULL
obtained	NULL
in	NULL
these	NULL
experiments	NULL
is	NULL
a	NULL
reflection	NULL
of	NULL
small	NULL
amounts	NULL
of	NULL
p65	NULL
as	NULL
opposed	NULL
to	NULL
inadequate	NULL
recognition	NULL
of	NULL
these	NULL
complexes	NULL
by	NULL
the	NULL
antibody	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
anti-p50	NULL
,	NULL
anti-p52	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
all	NULL
formed	NULL
specific	NULL
supershifted	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
Ii	NULL
protein-DNA	NULL
complexes	NULL
include	NULL
all	NULL
four	NULL
NF-kB/Rel	NULL
subunits	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

A	NULL
similar	NULL
analysis	NULL
of	NULL
Ii	NULL
kB-2	NULL
,	NULL
the	NULL
distal	NULL
site	NULL
,	NULL
showed	NULL
that	NULL
the	NULL
same	NULL
four	NULL
specific	NULL
antibodies	NULL
against	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
c-Rel	NULL
reacted	NULL
with	NULL
complexes	NULL
in	NULL
Raji	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

Anti-p50	NULL
eliminated	NULL
all	NULL
complexes	NULL
on	NULL
this	NULL
site	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
both	NULL
sites	NULL
in	NULL
Raji	NULL
cells	NULL
are	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
BINDING	NULL
SITES	NULL
IN	NULL
MHC	NULL
CLASS	NULL
II	NULL
Ii	NULL
PROMOTER	NULL
2931	NULL
A	NULL
Raji	NULL
Hg	NULL
u937	NULL
|	NULL
|	NULL
!	NULL

o	NULL
Q	NULL
¢	NULL
Competitor	NULL
2	NULL
&	NULL
$	NULL
Raji	NULL
H9	NULL
U937	NULL
aoa	NULL
``	NULL
arg	NULL
ay	NULL
J	NULL
Competitor	NULL
$	NULL
®	NULL
@	NULL
o	NULL
P	NULL
P	NULL
P-	NULL
9	NULL
fl	NULL
2	NULL
``	NULL
``	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
bind	NULL
complexes	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

Ii	NULL
kB-1	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Ii	NULL
kB-2	NULL
(	NULL
B	NULL
)	NULL
radiolabeled	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
H9	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
U937	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
cells	NULL
.	NULL

Specific	NULL
complex	NULL
formation	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
at	NULL
100-fold	NULL
molar	NULL
excess	NULL
:	NULL
Ii	NULL
xB-1	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
and	NULL
Ii	NULL
xB-2	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Circles	NULL
indicate	NULL
specific	NULL
complexes	NULL
.	NULL

activators	NULL
and	NULL
all	NULL
four	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
subunits	NULL
were	NULL
detected	NULL
in	NULL
complexes	NULL
on	NULL
these	NULL
sites	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
binding	NULL
of	NULL
NF-kB/Rel	NULL
factors	NULL
to	NULL
Ii	NULL
<	NULL
B-1	NULL
is	NULL
significantly	NULL
more	NULL
intense	NULL
than	NULL
is	NULL
binding	NULL
to	NULL
Ii	NULL
kB-2	NULL
.	NULL

Visible	NULL
complexes	NULL
with	NULL
Ii	NULL
kB-1	NULL
were	NULL
typically	NULL
evident	NULL
after	NULL
4	NULL
h	NULL
of	NULL
exposure	NULL
,	NULL
whereas	NULL
complexes	NULL
with	NULL
Ii	NULL
<	NULL
B-2	NULL
appeared	NULL
to	NULL
be	NULL
significantly	NULL
weaker	NULL
and	NULL
required	NULL
a	NULL
threefold	NULL
longer	NULL
exposure	NULL
.	NULL

This	NULL
may	NULL
affect	NULL
the	NULL
ability	NULL
to	NULL
detect	NULL
protein-DNA	NULL
interactions	NULL
by	NULL
the	NULL
genomic	NULL
footprinting	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Ii	NULL
kB-1	NULL
with	NULL
H9	NULL
nuclear	NULL
extracts	NULL
resulted	NULL
in	NULL
at	NULL
least	NULL
six	NULL
bands	NULL
which	NULL
were	NULL
recognized	NULL
by	NULL
NF-xB/Rel-specific	NULL
2932	NULL
BROWN	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

Ceti	NULL
.	NULL

BioL	NULL
.	NULL

Raji	NULL
U937	NULL
|	NULL
f	NULL
<	NULL
I	NULL
.	NULL

f	NULL
|	NULL
I	NULL
f	NULL
$	NULL
C	NULL
iG	NULL
x	NULL
~	NULL
o	NULL
a*	NULL
¥	NULL
~	NULL
&	NULL
0	NULL
P	NULL
¥	NULL
&	NULL
&	NULL
s	NULL
&	NULL
a	NULL
$	NULL
$	NULL
0	NULL
06	NULL
JY	NULL
&	NULL
C	NULL
$	NULL
§§§f¢§§§	NULL
if	NULL
&	NULL
4	NULL
£	NULL
&	NULL
£	NULL
ﬁfe/ffﬁé	NULL
’	NULL
&	NULL
Gems	NULL
3	NULL
is	NULL
‘	NULL
I'iii||	NULL
'	NULL
@	NULL
:	NULL
ska	NULL
``	NULL
seu	NULL
M	NULL
'	NULL
i	NULL
1°	NULL
O20	NULL
030	NULL
4	NULL
10	NULL
2	NULL
030	NULL
4	NULL
§	NULL
6	NULL
7	NULL
8	NULL
9	NULL
LOC	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Ti	NULL
xB-1-specific	NULL
complexes	NULL
contain	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
(	NULL
A	NULL
)	NULL
,	NULL
H9	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
U937	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
buffer	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
;	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
specific	NULL
antibodies	NULL
against	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
p65	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competitive	NULL
peptide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
;	NULL
or	NULL
IxBa	NULL
protein	NULL
(	NULL
last	NULL
lane	NULL
)	NULL
.	NULL

These	NULL
reactions	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
then	NULL
the	NULL
radiolabeled	NULL
Ii	NULL
kB-1	NULL
was	NULL
added	NULL
.	NULL

The	NULL
complexes	NULL
formed	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
on	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

All	NULL
antibodies	NULL
were	NULL
tested	NULL
with	NULL
probe	NULL
alone	NULL
to	NULL
identify	NULL
nonspecific	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Solid	NULL
circles	NULL
indicate	NULL
NF-	NULL
B/Refl-specific	NULL
complexes	NULL
,	NULL
and	NULL
open	NULL
circles	NULL
indicate	NULL
antibody	NULL
supershifted	NULL
complexes	NULL
.	NULL

antibodies	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Ii	NULL
xB-1	NULL
complexes	NULL
in	NULL
H9	NULL
reacted	NULL
weakly	NULL
with	NULL
anti-p65	NULL
,	NULL
forming	NULL
a	NULL
faint	NULL
supershifted	NULL
band	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Antibody	NULL
to	NULL
p50	NULL
reacted	NULL
strongly	NULL
with	NULL
the	NULL
lower	NULL
set	NULL
of	NULL
bands	NULL
such	NULL
that	NULL
the	NULL
entire	NULL
complex	NULL
was	NULL
displaced	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Anti-p52	NULL
also	NULL
reacted	NULL
with	NULL
H9	NULL
complexes	NULL
.	NULL

Anti-c-Rel	NULL
resulted	NULL
in	NULL
a	NULL
faint	NULL
supershifted	NULL
band	NULL
that	NULL
was	NULL
not	NULL
always	NULL
detectable	NULL
.	NULL

Thus	NULL
,	NULL
all	NULL
antibodies	NULL
appeared	NULL
to	NULL
react	NULL
with	NULL
H9-Ii	NULL
«	NULL
kB-1	NULL
complexes	NULL
,	NULL
which	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
site	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
the	NULL
complex	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
complex	NULL
formed	NULL
in	NULL
Raji	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
various	NULL
subunits	NULL
appear	NULL
to	NULL
be	NULL
different	NULL
between	NULL
Raji	NULL
and	NULL
H9	NULL
cells	NULL
.	NULL

Ii	NULL
<	NULL
kB-2-bound	NULL
H9	NULL
complexes	NULL
were	NULL
recognized	NULL
by	NULL
anti-p50	NULL
and	NULL
anti-pS52	NULL
but	NULL
not	NULL
by	NULL
anti-p65	NULL
or	NULL
anti-c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

Anti-p50	NULL
eliminated	NULL
both	NULL
bands	NULL
and	NULL
formed	NULL
a	NULL
strong	NULL
supershifted	NULL
complex	NULL
,	NULL
whereas	NULL
anti-p52	NULL
climinated	NULL
the	NULL
upper	NULL
com-plex	NULL
.	NULL

From	NULL
these	NULL
results	NULL
the	NULL
lower	NULL
complex	NULL
may	NULL
be	NULL
a	NULL
p50-p50	NULL
homodimer	NULL
and	NULL
the	NULL
upper	NULL
band	NULL
may	NULL
be	NULL
a	NULL
p50-p52	NULL
heterodimer	NULL
on	NULL
Ii	NULL
<	NULL
B-1	NULL
in	NULL
H9	NULL
extracts	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Raji	NULL
,	NULL
in	NULL
vitro	NULL
binding	NULL
was	NULL
readily	NULL
detectable	NULL
for	NULL
both	NULL
Ii	NULL
and	NULL
kB-2	NULL
by	NULL
using	NULL
H9	NULL
A	NULL
Raji	NULL
B	NULL
H9	NULL
nuclear	NULL
extracts	NULL
,	NULL
which	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
occupancy	NULL
of	NULL
both	NULL
sites	NULL
in	NULL
H9	NULL
cells	NULL
.	NULL

Complexes	NULL
in	NULL
U937	NULL
were	NULL
recognized	NULL
only	NULL
by	NULL
the	NULL
anti-p50	NULL
antibody	NULL
of	NULL
the	NULL
four	NULL
antisera	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
and	NULL
9C	NULL
)	NULL
.	NULL

On	NULL
Ii	NULL
«	NULL
B-1	NULL
the	NULL
lower	NULL
complex	NULL
was	NULL
eliminated	NULL
by	NULL
anti-p50	NULL
while	NULL
the	NULL
upper	NULL
complex	NULL
was	NULL
weakly	NULL
reactive	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
.	NULL

Ii	NULL
kB-2	NULL
bound	NULL
one	NULL
complex	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
completely	NULL
eliminated	NULL
by	NULL
anti-p50	NULL
and	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
any	NULL
other	NULL
antibodies	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

This	NULL
is	NULL
similar	NULL
to	NULL
findings	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
in	NULL
which	NULL
the	NULL
IL2-Ra	NULL
enhancer	NULL
NF-	NULL
«	NULL
B/Rel	NULL
site	NULL
bound	NULL
p50	NULL
in	NULL
U937	NULL
extracts	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
and	NULL
IFN-y-induced	NULL
U-105	NULL
MG	NULL
cells	NULL
were	NULL
also	NULL
tested	NULL
for	NULL
Ii	NULL
kB-binding	NULL
activity	NULL
.	NULL

Specific	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Ii	NULL
<	NULL
B-1	NULL
and	NULL
did	NULL
not	NULL
change	NULL
upon	NULL
IFN-y	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
unable	NULL
to	NULL
shift	NULL
any	NULL
of	NULL
these	NULL
complexes	NULL
.	NULL

Weak	NULL
binding	NULL
to	NULL
the	NULL
Ii	NULL
xB-2	NULL
probe	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
U-105	NULL
MG	NULL
extracts	NULL
,	NULL
requiring	NULL
10	NULL
times	NULL
the	NULL
exposures	NULL
needed	NULL
C	NULL
u937	NULL
i	NULL
v	NULL
$	NULL
$	NULL
o	NULL
$	NULL
9	NULL
&	NULL
2	NULL
We	NULL
?	NULL

5,5,5	NULL
5§¢r§ég	NULL
$	NULL
8	NULL
.	NULL

6-8	NULL
ﬁgciég	NULL
)	NULL
?	NULL

5-8	NULL
,	NULL
op	NULL
f	NULL
é	NULL
’	NULL
gﬁ	NULL
dgéé	NULL
’	NULL
$	NULL
§°§	NULL
a	NULL
?	NULL

49°	NULL
,	NULL
d	NULL
ang	NULL
6+	NULL
;	NULL
&	NULL
-~	NULL
-	NULL
;	NULL
}	NULL
-	NULL
Mik	NULL
U4	NULL
-	NULL
us	NULL
us	NULL
usus	NULL
~	NULL
Ukhusus	NULL
.	NULL

1	NULL
2	NULL
0g	NULL
~	NULL
405	NULL
06	NULL
~	NULL
T	NULL
B2	NULL
B=	NULL
wd	NULL
Rog	NULL
yl	NULL
Ngo	NULL
21.	NULL
poles	NULL
7	NULL
.	NULL

3	NULL
%	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Ii	NULL
xB-2-specific	NULL
complexes	NULL
contain	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Rfiji	NULL
(	NULL
A	NULL
)	NULL
,	NULL
H9	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
U937	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
were	NULL
incubated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
controls	NULL
,	NULL
or	NULL
IxBa	NULL
protein	NULL
as	NULL
indicated	NULL
and	NULL
reacted	NULL
with	NULL
radiolabeled	NULL
Ii	NULL
xB-2	NULL
.	NULL

Complexes	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Solid	NULL
circles	NULL
indicate	NULL
NF-xB/Rel-specific	NULL
complexes	NULL
,	NULL
and	NULL
open	NULL
circles	NULL
indicate	NULL
antibody	NULL
supershifted	NULL
complexes	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
for	NULL
Ii	NULL
xB-1	NULL
.	NULL

Anti-p50	NULL
was	NULL
able	NULL
to	NULL
supershift	NULL
this	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
by	NULL
adding	NULL
purified	NULL
IxBa	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
protein	NULL
to	NULL
in	NULL
vitro	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IxBa	NULL
only	NULL
weakly	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
some	NULL
complexes	NULL
when	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
;	NULL
however	NULL
,	NULL
other	NULL
bands	NULL
remained	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
9A	NULL
,	NULL
last	NULL
lane	NULL
of	NULL
the	NULL
respective	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
inhibitory	NULL
effects	NULL
of	NULL
IxBa	NULL
on	NULL
complex	NULL
formation	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
small	NULL
amounts	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
these	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
inability	NULL
to	NULL
abolish	NULL
these	NULL
complexes	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
small	NULL
amounts	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
in	NULL
these	NULL
extracts	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
observed	NULL
that	NULL
IxBa	NULL
can	NULL
associate	NULL
with	NULL
and	NULL
prevent	NULL
DNA	NULL
binding	NULL
of	NULL
complexes	NULL
containing	NULL
p65	NULL
and	NULL
c-Rel	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
show	NULL
that	NULL
the	NULL
Ii	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
sites	NULL
bind	NULL
NF-	NULL
«	NULL
B/Rel	NULL
subunits	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
data	NULL
is	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
in	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
Ii	NULL
NF-	NULL
«	NULL
xB/Re	NULL
!	NULL

sites	NULL
have	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
the	NULL
complexes	NULL
formed	NULL
were	NULL
recognized	NULL
only	NULL
by	NULL
antisera	NULL
against	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
whereas	NULL
in	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

sites	NULL
have	NULL
a	NULL
positive	NULL
regulatory	NULL
function	NULL
the	NULL
complexes	NULL
contained	NULL
detectable	NULL
amounts	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
in	NULL
addition	NULL
to	NULL
p50	NULL
and	NULL
p52	NULL
.	NULL

Some	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
antibody	NULL
and	NULL
may	NULL
represent	NULL
unidentified	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
some	NULL
proteins	NULL
,	NULL
when	NULL
contained	NULL
in	NULL
certain	NULL
complexes	NULL
,	NULL
can	NULL
not	NULL
be	NULL
recognized	NULL
by	NULL
these	NULL
antibodies	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
we	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
the	NULL
in	NULL
vivo	NULL
genomic	NULL
footprint	NULL
of	NULL
two	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
human	NULL
Ii	NULL
promoter	NULL
and	NULL
demonstrate	NULL
that	NULL
they	NULL
have	NULL
contrasting	NULL
regulatory	NULL
functions	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
also	NULL
present	NULL
extensive	NULL
analysis	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
!	NULL

complexes	NULL
formed	NULL
on	NULL
these	NULL
sites	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Ii	NULL
«	NULL
B-1	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
Ii-expressing	NULL
B-	NULL
and	NULL
T-lymphoid	NULL
cell	NULL
lines	NULL
and	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
glioblastoma	NULL
cells	NULL
,	NULL
and	NULL
primary	NULL
brain	NULL
glial	NULL
cells	NULL
.	NULL

Ii	NULL
kB-2	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B-cell	NULL
lines	NULL
and	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
H9	NULL
cells	NULL
,	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
glioblastoma	NULL
cells	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
revealed	NULL
binding	NULL
to	NULL
proteins	NULL
at	NULL
NF-	NULL
«	NULL
kB/Re	NULL
!	NULL

sites	NULL
with	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
vitro	NULL
binding	NULL
studies	NULL
revealed	NULL
that	NULL
both	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
were	NULL
bound	NULL
by	NULL
NF-kB/Rel-containing	NULL
complexes	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
all	NULL
expressing	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
different	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
subunits	NULL
bound	NULL
positive	NULL
sites	NULL
compared	NULL
with	NULL
those	NULL
that	NULL
bound	NULL
negative	NULL
regulatory	NULL
sites	NULL
.	NULL

Collectively	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
function	NULL
of	NULL
Ii	NULL
NF-	NULL
«	NULL
kB/Re	NULL
!	NULL

elements	NULL
appears	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
different	NULL
known	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
in	NULL
a	NULL
cell-type-dependent	NULL
fashion	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
are	NULL
important	NULL
cis-acting	NULL
elements	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
inducible	NULL
,	NULL
tissue-re-stricted	NULL
,	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
Ii	NULL
NF-	NULL
«	NULL
xB/Re	NULL
!	NULL

site	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
B-cell-specific	NULL
activator	NULL
as	NULL
well	NULL
as	NULL
a	NULL
TNF-a	NULL
@	NULL
-responsive	NULL
element	NULL
(	NULL
40	NULL
,	NULL
52	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
Ii	NULL
NF-xkB/Re	NULL
!	NULL

binding	NULL
site	NULL
and	NULL
human	NULL
Ii	NULL
kB-1	NULL
are	NULL
nearly	NULL
identical	NULL
,	NULL
having	NULL
only	NULL
a	NULL
one-nucleotide	NULL
difference	NULL
.	NULL

This	NULL
study	NULL
presents	NULL
observations	NULL
on	NULL
the	NULL
cell-type-specific	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
Ii	NULL
gene	NULL
and	NULL
shows	NULL
that	NULL
Ii	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
elements	NULL
have	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
functions	NULL
that	NULL
are	NULL
cell	NULL
type	NULL
dependent	NULL
.	NULL

Ii	NULL
«	NULL
B-2	NULL
dramatically	NULL
repressed	NULL
a	NULL
heterologous	NULL
promoter	NULL
when	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
in	NULL
TKCAT	NULL
plasmids	NULL
in	NULL
U937	NULL
,	NULL
a	NULL
promonocytic	NULL
cell	NULL
line	NULL
.	NULL

Ii	NULL
kB-1	NULL
did	NULL
not	NULL
repress	NULL
the	NULL
heterologous	NULL
TK	NULL
promoter	NULL
.	NULL

A	NULL
likely	NULL
explanation	NULL
for	NULL
these	NULL
results	NULL
is	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
repression	NULL
by	NULL
Ii	NULL
kB-1	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
BINDING	NULL
SITES	NULL
IN	NULL
MHC	NULL
CLASS	NULL
II	NULL
li	NULL
PROMOTER	NULL
2933	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
context	NULL
of	NULL
the	NULL
Ii	NULL
promoter	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
function	NULL
of	NULL
some	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
separate	NULL
element	NULL
that	NULL
acts	NULL
from	NULL
a	NULL
distance	NULL
.	NULL

This	NULL
mechanism	NULL
has	NULL
been	NULL
described	NULL
for	NULL
a	NULL
Dorsal	NULL
binding	NULL
site	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
and	NULL
for	NULL
an	NULL
immunoglobulin	NULL
Ig	NULL
xB	NULL
site	NULL
(	NULL
42	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
Ii	NULL
<	NULL
B-1	NULL
functions	NULL
in	NULL
this	NULL
way	NULL
since	NULL
it	NULL
is	NULL
position	NULL
dependent	NULL
;	NULL
however	NULL
,	NULL
Ii	NULL
xB-2	NULL
clearly	NULL
does	NULL
not	NULL
have	NULL
these	NULL
restrictions	NULL
.	NULL

In	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
and	NULL
gene	NULL
expression	NULL
tend	NULL
to	NULL
correlate	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
studies	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
I	NULL
and	NULL
class	NULL
II	NULL
,	NULL
invariant-chain	NULL
,	NULL
tyrosine	NULL
aminotransferase	NULL
,	NULL
muscle	NULL
creatine	NULL
kinase	NULL
,	NULL
mouse	NULL
metallothionein	NULL
I	NULL
,	NULL
and	NULL
mouse	NULL
transthy-retin	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
16	NULL
,	NULL
27	NULL
,	NULL
33	NULL
,	NULL
36	NULL
,	NULL
50	NULL
)	NULL
.	NULL

This	NULL
correlation	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
observations	NULL
of	NULL
in	NULL
vivo	NULL
interactions	NULL
on	NULL
the	NULL
Ii	NULL
kB-1	NULL
element	NULL
in	NULL
expressing	NULL
B-	NULL
and	NULL
T-lymphocytic	NULL
cell	NULL
lines	NULL
and	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
strong	NULL
interaction	NULL
on	NULL
Ii	NULL
«	NULL
kB-2	NULL
in	NULL
H9	NULL
cells	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
an	NULL
observed	NULL
in	NULL
vivo	NULL
protection	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
as	NULL
noted	NULL
on	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
of	NULL
c-fos	NULL
during	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
15	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
other	NULL
situations	NULL
interactions	NULL
are	NULL
not	NULL
observed	NULL
on	NULL
known	NULL
transcriptional	NULL
elements	NULL
such	NULL
as	NULL
the	NULL
S	NULL
element	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
Ii	NULL
genes	NULL
(	NULL
12	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
binding	NULL
was	NULL
also	NULL
not	NULL
observed	NULL
with	NULL
Ii	NULL
kB-2	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
the	NULL
glioblastoma	NULL
cell	NULL
line	NULL
,	NULL
where	NULL
the	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
proteins	NULL
in	NULL
these	NULL
extracts	NULL
was	NULL
demonstrated	NULL
by	NULL
in	NULL
vitro	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
9	NULL
;	NULL
also	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
in	NULL
vivo	NULL
interactions	NULL
on	NULL
known	NULL
regulatory	NULL
sites	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
technical	NULL
limitations	NULL
of	NULL
the	NULL
assay	NULL
or	NULL
to	NULL
the	NULL
inherent	NULL
low	NULL
affinity	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
this	NULL
site	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
probably	NULL
the	NULL
case	NULL
because	NULL
in	NULL
vitro	NULL
binding	NULL
of	NULL
Ii	NULL
xB-2	NULL
is	NULL
significantly	NULL
weaker	NULL
than	NULL
at	NULL
«	NULL
B-1	NULL
and	NULL
requires	NULL
3-	NULL
and	NULL
10-fold	NULL
longer	NULL
exposures	NULL
to	NULL
rival	NULL
the	NULL
intensity	NULL
of	NULL
Ii	NULL
kB-1	NULL
binding	NULL
for	NULL
Raji	NULL
and	NULL
U-105	NULL
MG	NULL
nuclear	NULL
extracts	NULL
,	NULL
respectively	NULL
.	NULL

An	NULL
intriguing	NULL
observation	NULL
is	NULL
the	NULL
induction	NULL
of	NULL
in	NULL
vivo	NULL
protections	NULL
at	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
,	NULL
Ii	NULL
kB-1	NULL
,	NULL
upon	NULL
IFN-y	NULL
treatment	NULL
of	NULL
the	NULL
glioblastoma	NULL
cells	NULL
.	NULL

The	NULL
timing	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
Ii	NULL
xB-1	NULL
is	NULL
such	NULL
that	NULL
maximal	NULL
binding	NULL
is	NULL
delayed	NULL
until	NULL
48	NULL
h	NULL
,	NULL
which	NULL
coincides	NULL
with	NULL
the	NULL
decrease	NULL
in	NULL
transcription	NULL
detected	NULL
after	NULL
this	NULL
at	NULL
48	NULL
to	NULL
72	NULL
h	NULL
in	NULL
the	NULL
run-on	NULL
experiments	NULL
.	NULL

During	NULL
IFN-y	NULL
induction	NULL
the	NULL
endogenous	NULL
promoter	NULL
becomes	NULL
available	NULL
for	NULL
factor	NULL
binding	NULL
and	NULL
becomes	NULL
bound	NULL
at	NULL
an	NULL
array	NULL
of	NULL
sites	NULL
including	NULL
Ii	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
ISRE	NULL
at	NULL
24	NULL
h	NULL
after	NULL
treatment	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
occupancy	NULL
of	NULL
these	NULL
positive	NULL
and	NULL
negative	NULL
sites	NULL
during	NULL
IFN-y	NULL
induction	NULL
may	NULL
be	NULL
sequential	NULL
,	NULL
with	NULL
binding	NULL
of	NULL
the	NULL
positive	NULL
sites	NULL
occurring	NULL
first	NULL
and	NULL
binding	NULL
of	NULL
the	NULL
negative	NULL
site	NULL
delayed	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
occupation	NULL
of	NULL
Ii	NULL
kB-1	NULL
may	NULL
lead	NULL
to	NULL
subsequent	NULL
down-regulation	NULL
of	NULL
the	NULL
Ii	NULL
gene	NULL
.	NULL

Another	NULL
instance	NULL
of	NULL
a	NULL
repressor	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
site	NULL
which	NULL
is	NULL
bound	NULL
in	NULL
vivo	NULL
is	NULL
the	NULL
Ii	NULL
xB-2	NULL
site	NULL
,	NULL
which	NULL
has	NULL
clear	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
H9	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
!	NULL

binding	NULL
to	NULL
a	NULL
target	NULL
site	NULL
can	NULL
lead	NULL
to	NULL
either	NULL
enhanced	NULL
or	NULL
repressed	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
in	NULL
vivo	NULL
interactions	NULL
on	NULL
Ii	NULL
NF-	NULL
«	NULL
kB/Re	NULL
!	NULL

sites	NULL
that	NULL
have	NULL
a	NULL
negative	NULL
regulatory	NULL
role	NULL
suggests	NULL
that	NULL
these	NULL
elements	NULL
are	NULL
bound	NULL
by	NULL
proteins	NULL
that	NULL
mediate	NULL
repression	NULL
.	NULL

We	NULL
extensively	NULL
analyzed	NULL
complexes	NULL
formed	NULL
on	NULL
Ii	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

sites	NULL
in	NULL
in	NULL
vitro	NULL
binding	NULL
studies	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
types	NULL
to	NULL
assess	NULL
whether	NULL
a	NULL
specific	NULL
pattern	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
positive	NULL
or	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
to	NULL
9	NULL
;	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
Ii	NULL
sites	NULL
were	NULL
activators	NULL
,	NULL
the	NULL
sites	NULL
are	NULL
bound	NULL
by	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
was	NULL
unique	NULL
to	NULL
activator	NULL
kB	NULL
sites	NULL
and	NULL
was	NULL
not	NULL
observed	NULL
on	NULL
the	NULL
negative	NULL
sites	NULL
.	NULL

Importantly	NULL
,	NULL
p65	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
strong	NULL
transactivator	NULL
through	NULL
other	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
3	NULL
,	NULL
45	NULL
,	NULL
47	NULL
)	NULL
.	NULL

c-Rel	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
an	NULL
activation	NULL
domain	NULL
but	NULL
functions	NULL
only	NULL
weakly	NULL
through	NULL
an	NULL
NF-KB	NULL
site	NULL
.	NULL

The	NULL
negative	NULL
Ii	NULL
kB	NULL
sites	NULL
bound	NULL
proteins	NULL
identified	NULL
as	NULL
p50	NULL
and	NULL
pS2	NULL
,	NULL
which	NULL
2934	NULL
BROWN	NULL
ET	NULL
AL	NULL
.	NULL

correlates	NULL
with	NULL
previously	NULL
published	NULL
observations	NULL
.	NULL

In	NULL
cotrans-fection	NULL
experiments	NULL
,	NULL
p50	NULL
overexpression	NULL
resulted	NULL
in	NULL
repression	NULL
of	NULL
p65	NULL
transactivation	NULL
(	NULL
through	NULL
a	NULL
promoter	NULL
containing	NULL
two	NULL
kB	NULL
sites	NULL
linked	NULL
to	NULL
a	NULL
truncated	NULL
c-fos	NULL
promoter	NULL
)	NULL
(	NULL
45	NULL
)	NULL
and	NULL
repression	NULL
of	NULL
an	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
EL-4	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
p50	NULL
inhibited	NULL
induction	NULL
by	NULL
TPA	NULL
(	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
)	NULL
activation	NULL
through	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
kB	NULL
sites	NULL
,	NULL
which	NULL
was	NULL
reversed	NULL
by	NULL
an	NULL
IxB	NULL
,	NULL
Bcel-3	NULL
(	NULL
20	NULL
)	NULL
.	NULL

From	NULL
previous	NULL
studies	NULL
,	NULL
p50	NULL
homodimers	NULL
have	NULL
negative	NULL
regulatory	NULL
roles	NULL
on	NULL
known	NULL
NF-	NULL
«	NULL
B/Rel	NULL
sites	NULL
(	NULL
26	NULL
)	NULL
whereas	NULL
on	NULL
other	NULL
sites	NULL
they	NULL
appear	NULL
to	NULL
be	NULL
transactivators	NULL
(	NULL
21	NULL
)	NULL
.	NULL

This	NULL
correlates	NULL
with	NULL
our	NULL
results	NULL
,	NULL
which	NULL
show	NULL
that	NULL
p50	NULL
is	NULL
present	NULL
in	NULL
complexes	NULL
on	NULL
repressor	NULL
sites	NULL
in	NULL
H9	NULL
and	NULL
U937	NULL
nuclear	NULL
extracts	NULL
as	NULL
well	NULL
as	NULL
on	NULL
activator	NULL
sites	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
p52	NULL
in	NULL
transcription	NULL
is	NULL
less	NULL
clear	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transactivate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
p65	NULL
(	NULL
18	NULL
,	NULL
39	NULL
)	NULL
.	NULL

On	NULL
the	NULL
Ii	NULL
sites	NULL
,	NULL
p52	NULL
is	NULL
involved	NULL
in	NULL
complexes	NULL
with	NULL
different	NULL
functions	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
.	NULL

Some	NULL
complexes	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
antibody	NULL
in	NULL
these	NULL
assays	NULL
,	NULL
perhaps	NULL
owing	NULL
to	NULL
different	NULL
protein	NULL
conformations	NULL
in	NULL
complexes	NULL
with	NULL
different	NULL
components	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
an	NULL
undetected	NULL
or	NULL
unknown	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
these	NULL
complexes	NULL
.	NULL

Such	NULL
a	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
may	NULL
determine	NULL
the	NULL
cell-type-specific	NULL
function	NULL
of	NULL
the	NULL
site	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
this	NULL
work	NULL
demonstrates	NULL
that	NULL
the	NULL
role	NULL
of	NULL
Ii	NULL
«	NULL
kB-1	NULL
and	NULL
«	NULL
B-2	NULL
regulatory	NULL
elements	NULL
is	NULL
cell	NULL
dependent	NULL
and	NULL
probably	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
disparate	NULL
factors	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
detected	NULL
binding	NULL
of	NULL
both	NULL
activator	NULL
and	NULL
repressor	NULL
sites	NULL
.	NULL

Activator	NULL
functions	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
binding	NULL
activity	NULL
identified	NULL
as	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
c-Rel	NULL
in	NULL
lymphocytic	NULL
cell	NULL
lines	NULL
.	NULL

Repressor	NULL
functions	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
p50	NULL
and	NULL
p52	NULL
binding	NULL
activity	NULL
in	NULL
H9	NULL
T	NULL
cells	NULL
and	NULL
U937	NULL
promonocytic	NULL
cells	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
complicated	NULL
promoter	NULL
,	NULL
which	NULL
differentially	NULL
regulates	NULL
Ii	NULL
expression	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

e	NULL
ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Cancer	NULL
Institute	NULL
grant	NULL
CA48185	NULL
and	NULL
National	NULL
Multiple	NULL
Sclerosis	NULL
Society	NULL
grant	NULL
RG1785	NULL
.	NULL

J.P.-Y.T	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Faculty	NULL
award	NULL
.	NULL

K.L.W	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
an	NULL
Arthritis	NULL
Foundation	NULL
postdoctoral	NULL
fellow-ship	NULL
.	NULL

M.W.L	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
NIH	NULL
predoctoral	NULL
training	NULL
grant	NULL
GMO08332-03	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
physiology	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
,	NULL
p.	NULL
409-432	NULL
.	NULL

In	NULL
P.	NULL
Cohen	NULL
and	NULL
J.	NULL
G.	NULL
Foulkes	NULL
,	NULL
Hormonal	NULL
control	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Elsevier/North	NULL
Holland	NULL
Biomedical	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

3	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-kB	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
:	NULL
1875-1879	NULL
.	NULL

4	NULL
.	NULL

Barr	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
F.	NULL
Saunders	NULL
.	NULL

1991	NULL
.	NULL

Interferon-y-inducible	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
invariant	NULL
chain	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:3475-3481	NULL
.	NULL

5	NULL
.	NULL

Becker	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
S.	NULL
Ruppert	NULL
,	NULL
and	NULL
G.	NULL
Schiitz	NULL
.	NULL

1987	NULL
.	NULL

Genomic	NULL
footprinting	NULL
reveals	NULL
cell	NULL
type-specific	NULL
DNA	NULL
binding	NULL
of	NULL
ubiquitous	NULL
factors	NULL
.	NULL

Cell	NULL
51:435-443	NULL
.	NULL

6	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

The	NULL
IB	NULL
proteins	NULL
:	NULL
multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2064-2070	NULL
.	NULL

7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphor	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Mor	NULL
.	NULL

Cer	NULL
.	NULL

Bro	NULL
.	NULL

ylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310.	NULL
.	NULL

Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
major	NULL
histocom-	NULL
patibility	NULL
complex	NULL
class-II	NULL
genes	NULL
:	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
other	NULL
letters	NULL
of	NULL
the	NULL
alphabet	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:681-715.	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
related	NULL
proteins	NULL
:	NULL
Rel/dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:135-140	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Ann	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

Brown	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
L.	NULL
Barr	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1991	NULL
.	NULL

Sequences	NULL
homologous	NULL
to	NULL
class	NULL
II	NULL
MHC	NULL
W	NULL
,	NULL
X	NULL
,	NULL
and	NULL
Y	NULL
elements	NULL
mediate	NULL
constitutive	NULL
and	NULL
interferon-y	NULL
induced	NULL
expression	NULL
of	NULL
human	NULL
class	NULL
-associated	NULL
invariant	NULL
chain	NULL
gene	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3183-3189	NULL
.	NULL

Brown	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
K.	NULL
L.	NULL
Wright	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
MHC	NULL
class	NULL
II	NULL
associated	NULL
invariant	NULL
chain	NULL
gene	NULL
promoter	NULL
:	NULL
functional	NULL
analysis	NULL
and	NULL
in	NULL
vivo	NULL
protein/DNA	NULL
interactions	NULL
of	NULL
constitutive	NULL
and	NULL
IFN-y	NULL
induced	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:26328-26333	NULL
.	NULL

Cresswell	NULL
,	NULL
P.	NULL
1992	NULL
.	NULL

Chemistry	NULL
and	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
invariant	NULL
chain	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

4:87-92.	NULL
de	NULL
Préval	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Lisowska-Grospierre	NULL
,	NULL
M.	NULL
Loche	NULL
,	NULL
C.	NULL
Griscelli	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
trans-acting	NULL
class	NULL
II	NULL
regulatory	NULL
gene	NULL
unlinked	NULL
to	NULL
the	NULL
MHC	NULL
controls	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
318:291-293	NULL
.	NULL

Dey	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
W.	NULL
Nebert	NULL
,	NULL
and	NULL
K.	NULL
Ozato	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
and	NULL
the	NULL
cAMP	NULL
and	NULL
serum	NULL
response	NULL
elements	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
are	NULL
constitutively	NULL
occupied	NULL
in	NULL
vivo	NULL
.	NULL

DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

10:537-544	NULL
.	NULL

Dey	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
M.	NULL
Thornton	NULL
,	NULL
M.	NULL
Lonergan	NULL
,	NULL
S.	NULL
M.	NULL
Weissman	NULL
,	NULL
J.	NULL
W.	NULL
Chamberlain	NULL
,	NULL
and	NULL
K.	NULL
Ozato	NULL
.	NULL

1992	NULL
.	NULL

Occupancy	NULL
of	NULL
upstream	NULL
regulatory	NULL
sites	NULL
in	NULL
vivo	NULL
coincides	NULL
with	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
in	NULL
mouse	NULL
tissues	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3590-3599	NULL
.	NULL

Doyle	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
J.	NULL
Ford	NULL
,	NULL
P.	NULL
D.	NULL
Ponath	NULL
,	NULL
T.	NULL
Spies	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
class	NULL
HM-associated	NULL
invariant	NULL
chain	NULL
gene	NULL
in	NULL
normal	NULL
and	NULL
mutant	NULL
B	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4590-4594	NULL
.	NULL

Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
T.	NULL
F.	NULL
Kowalik	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
E.-S.	NULL
Huang	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

Dimerization	NULL
of	NULL
NF-kB2	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
regulates	NULL
DNA	NULL
binding	NULL
,	NULL
transcriptional	NULL
activation	NULL
,	NULL
and	NULL
inhibition	NULL
by	NULL
an	NULL
IxB-	NULL
«	NULL
(	NULL
MAD-3	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1315-1322	NULL
.	NULL

Eades	NULL
,	NULL
A.-M.	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
IFN-y	NULL
response	NULL
of	NULL
the	NULL
murine	NULL
invariant	NULL
chain	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
enhancer	NULL
that	NULL
includes	NULL
several	NULL
MHC	NULL
class	NULL
II	NULL
consensus	NULL
elements	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144	NULL
;	NULL
4399-4409	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
,	NULL
1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bcl-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
p50/NF-	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
359:339-342	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-kB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6775-787	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Kara	NULL
.	NULL

1992	NULL
.	NULL

Sequences	NULL
and	NULL
factors	NULL
:	NULL
a	NULL
guide	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:1	NULL
3-50	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
S.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel-participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
sys-tem	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62	NULL
.	NULL

Ip	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
R.	NULL
Kraut	NULL
,	NULL
M.	NULL
Levine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rushlow	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
dorsal	NULL
morphogen	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
long-range	NULL
repression	NULL
element	NULL
in	NULL
Drosophila	NULL
.	NULL

Cell	NULL
64:439-446	NULL
.	NULL

Jiang	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Levine	NULL
.	NULL

1993	NULL
.	NULL

Binding	NULL
affinities	NULL
and	NULL
cooperative	NULL
interactions	NULL
with	NULL
bHLH	NULL
activators	NULL
delimit	NULL
threshold	NULL
responses	NULL
to	NULL
the	NULL
dorsal	NULL
gradient	NULL
morphogen	NULL
.	NULL

Cell	NULL
72:741-752	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
M.	NULL
Grilli	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:1452-1456	NULL
.	NULL

Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1991.	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
:	NULL
bare	NULL
promoter	NULL
in	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

Science	NULL
252:709-712	NULL
.	NULL

Kaufman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Weinberg	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
Vou	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40.	NULL
expression	NULL
of	NULL
the	NULL
50-	NULL
and	NULL
65-kD	NULL
Rel-related	NULL
subunits	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
is	NULL
differentially	NULL
regulated	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:121-129	NULL
.	NULL

Koch	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Harris	NULL
.	NULL

1984	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
the	NULL
invariant	NULL
chain	NULL
in	NULL
mouse	NULL
tumor	NULL
cells	NULL
:	NULL
relationship	NULL
to	NULL
B	NULL
lymphoid	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

132:12-15	NULL
.	NULL

Konig	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Ponta	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1992	NULL
.	NULL

Interference	NULL
between	NULL
pathway-specific	NULL
transcription	NULL
factors	NULL
:	NULL
glu-cocorticoids	NULL
antagonize	NULL
phorbol	NULL
ester-induced	NULL
AP-1	NULL
activity	NULL
without	NULL
altering	NULL
AP-1	NULL
site	NULL
occupation	NULL
in	NULL
vivo	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:2241-2246	NULL
.	NULL

Kudo	NULL
,	NULL
J.	NULL
,	NULL
L.-Y	NULL
.	NULL

Chao	NULL
,	NULL
F.	NULL
Narni	NULL
,	NULL
and	NULL
G.	NULL
F.	NULL
Saunders	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
encoding	NULL
the	NULL
invariant	NULL
y-chain	NULL
of	NULL
the	NULL
class	NULL
II	NULL
histocompatibility	NULL
antigens	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:8827-8840	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J.	NULL
D.	NULL
Roberts	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Zakour	NULL
.	NULL

1987	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotypic	NULL
selection	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

154:367-382	NULL
.	NULL

Mirkovitch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rapid	NULL
in	NULL
vivo	NULL
footprinting	NULL
technique	NULL
identifies	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
TTR	NULL
gene	NULL
in	NULL
the	NULL
mouse	NULL
liver	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:83-93	NULL
.	NULL

Momburg	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Koch	NULL
,	NULL
P.	NULL
Moller	NULL
,	NULL
G.	NULL
Moldenhauer	NULL
,	NULL
G.	NULL
W.	NULL
Butcher	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Hammerting	NULL
.	NULL

1986	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
Ia	NULL
and	NULL
Ia-associated	NULL
invariant	NULL
chain	NULL
in	NULL
mouse	NULL
tissues	NULL
after	NULL
in	NULL
vivo	NULL
treatment	NULL
with	NULL
IFN-y	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

136:940-948	NULL
.	NULL

Momburg	NULL
,	NULL
F.	NULL
,	NULL
K.	NULL
Koretz	NULL
,	NULL
A	NULL
.	NULL

Von	NULL
Herbay	NULL
,	NULL
and	NULL
P.	NULL
Moller	NULL
,	NULL
1988	NULL
.	NULL

Nonimmune	NULL
human	NULL
cells	NULL
can	NULL
express	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
invariant	NULL
chain-an	NULL
immunohistological	NULL
study	NULL
on	NULL
normal	NULL
and	NULL
chronically	NULL
inflamed	NULL
small	NULL
intestine	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

72:367-372	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

/n	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780-786	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
C.	NULL
A.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
O.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5:444-448	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
inhibitory	NULL
ankyrin	NULL
and	NULL
activator	NULL
Rel	NULL
proteins	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2:211-220	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-kB	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Pessara	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
N.	NULL
Koch	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
IT-asso-ciated	NULL
invariant	NULL
chain	NULL
by	NULL
binding	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
to	NULL
a	NULL
promoter	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4146-4154	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
BINDING	NULL
SITES	NULL
IN	NULL
MHC	NULL
CLASS	NULL
II	NULL
Ii	NULL
PROMOTER	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

2935	NULL
Phares	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
kB	NULL
enhancer	NULL
motifs	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
simian	NULL
virus	NULL
40	NULL
recognize	NULL
different	NULL
binding	NULL
activities	NULL
in	NULL
human	NULL
Jurkat	NULL
and	NULL
H9	NULL
T	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
NF-	NULL
«	NULL
kB-independent	NULL
activation	NULL
of	NULL
the	NULL
xB	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7490-7498	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Silencing	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
kappa	NULL
gene	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1431-1437	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253.	NULL
.	NULL

Sasaki	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
W.	NULL
Levinson	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1989	NULL
.	NULL

Comparison	NULL
and	NULL
quantitation	NULL
of	NULL
Ia	NULL
antigen	NULL
expression	NULL
on	NULL
cultured	NULL
macroglia	NULL
and	NULL
ameboid	NULL
microglia	NULL
from	NULL
Lewis	NULL
rat	NULL
cerebral	NULL
cortex	NULL
:	NULL
analyses	NULL
and	NULL
implications	NULL
.	NULL

J.	NULL
Neuroimmunol	NULL
.	NULL

25:63-74	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
k	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
posttranslational	NULL
mecha-nism	NULL
.	NULL

Cell	NULL
47:921-928	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
associations	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
Rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
3964-3974	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
the	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5169-5181	NULL
.	NULL

Viville	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Neefjes	NULL
,	NULL
V.	NULL
Lotteau	NULL
,	NULL
A.	NULL
Dierich	NULL
,	NULL
M.	NULL
Lemeur	NULL
,	NULL
H.	NULL
Ploegh	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1993	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
MHC	NULL
class	NULL
-associated	NULL
invariant	NULL
chain	NULL
.	NULL

Cell	NULL
72:635-648	NULL
.	NULL

Wright	NULL
,	NULL
K.	NULL
L.	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
promoter	NULL
:	NULL
cell-specific	NULL
interaction	NULL
at	NULL
the	NULL
octamer	NULL
site	NULL
and	NULL
up-regulation	NULL
of	NULL
X	NULL
box	NULL
binding	NULL
by	NULL
interferon-y	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7601-7605	NULL
.	NULL

Yuan	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Tucker	NULL
.	NULL

1984	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
-8	NULL
heavy	NULL
chain	NULL
locus	NULL
in	NULL
normal	NULL
murine	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160:564-583	NULL
.	NULL

Zhu	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
P.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
control	NULL
of	NULL
the	NULL
invariant	NULL
chain	NULL
gene	NULL
involves	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
common	NULL
to	NULL
and	NULL
distinct	NULL
from	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3906-3916	NULL
.	NULL

